Patient monitoring system

Description

INCORPORATION BY REFERENCE TO ANY PRIORITY APPLICATIONS

Any and all applications for which a foreign or domestic priority claim is identified in the Application Data Sheet as filed with the present application are hereby incorporated by reference under 37 CFR 1.57.

BACKGROUND

Hospitals, nursing homes, and other wearer care facilities typically include patient monitoring devices at one or more bedsides in the facility. Patient monitoring devices generally include sensors, processing equipment, and displays for obtaining and analyzing a medical wearer's physiological parameters such as blood oxygen saturation level, respiratory rate, and the like. Clinicians, including doctors, nurses, and other users, use the physiological parameters obtained from patient monitors to diagnose illnesses and to prescribe treatments. Clinicians also use the physiological parameters to monitor wearers during various clinical situations to determine whether to increase the level of medical care given to wearers. Additionally, monitoring equipment is often used in corporate care facilities, fitness facilities, recreational and home care applications, as well as mobile or other emergency care environments.

Blood pressure (which can refer to diastolic pressure, systolic pressure, and/or some combination or mathematical representation of same) considered one of the principal vital signs, is one example of a physiological parameter that can be monitored. Blood Pressure monitoring is an important indicator of a wearer's cardiovascular status. Many devices allow blood pressure to be measured by manual or digital sphygmomanometer systems that utilize an inflatable cuff applied to a person's arm. The term “sphygmomanoter” is meant to receive its ordinary broad meaning known to an artisan to include devices used to measure blood pressure. These devices often include an inflatable cuff to restrict blood flow and a device capable of measuring the pressure. Other device(s) are used to determine at what pressure blood flow is just starting and at what pressure it is just unimpeded, commonly referred to as “systolic” and “diastolic,” respectively. The term “systolic blood pressure” is meant to receive its ordinary broad meaning known to an artisan to include the pressure exerted on the bloodstream by the heart when it contracts, forcing blood from the ventricles of the heart into the pulmonary artery and the aorta. The term “diastolic blood pressure” is meant to receive its ordinary broad meaning known to an artisan to include the pressure in the bloodstream when the heart relaxes and dilates, filling with blood.

In a typical pressure monitoring system, a hand actuated pump or an electric motor inflates the inflatable cuff to a pressure level at or above the expected systolic pressure of the wearer and high enough to occlude an artery. Automated or motorized blood pressure monitoring systems use a motor or pump to inflate the inflatable cuff, while manual blood pressure monitors typically use an inflation bulb. As the air from the inflatable cuff is slowly released, the wearer's blood pressure can be determined by detecting Korotkoff sounds using a stethoscope or other detection device placed over an artery.

Alternatively, digital sphygmomanometers compute diastolic and systolic pressure as the inflatable cuff deflates based on the oscillations observed by a pressure sensor on the cuff. For example, some digital sphygmomanometers calculate the systolic blood pressure as the pressure at which the oscillations become detectable and the diastolic pressure as the pressure at which the oscillations are no longer detectable. Other digital sphygmomanometers calculate the mean arterial pressure first (the pressure on the cuff at which the oscillations have the maximum amplitude). The diastolic and systolic pressures are then calculated based on their fractional relationship with the mean arterial pressure. Other algorithms are used, such as identifying the change in slope of the amplitude of the pressure fluctuations to calculate the diastolic pressure.

As mentioned above, the foregoing methods of determining blood pressure include inflating the cuff to a pressure high enough to occlude an artery and then determining blood pressure during deflation of the inflatable cuff. Occluding the artery and then determining blood pressure during deflation can have a number of drawbacks. For example, inflating the inflatable cuff to a pressure higher than systolic pressure can cause pain and discomfort to the wearer. Other adverse effects can include limb edema, venous stasis, peripheral neuropathy, etc, or simply wearer interruption. In addition, as the artery is completely occluded prior to each measurement, sufficient time must elapse between measurements to ensure accurate results. Furthermore, manual systems make it difficult to measure blood pressure during inflation of the inflatable cuff due to the difficult of inflating the inflatable cuff at an approximately constant rate using an inflation bulb.

Digital blood pressure monitors can have additional drawbacks. The motors used to pump gas into the cuff are often noisy and can disturb wearers at rest. This is especially problematic in recovery situations. In addition to auditory noise in automated or motorized systems, the motors can cause electrical noise in sensor signals making signal processing used to identify reference points for blood pressure detection unreliable and difficult. Furthermore, portable motorized blood pressure monitors require a significant amount of power to produce the air pressure required to inflate the cuff. Since batteries are often used to provide power, designers often use large batteries and/or batteries that frequently need to be recharged or replaced. When a large batter is chosen, its size often offsets the goals of portability as an appropriate housing becomes more cumbersome and less convenient.

SUMMARY

Based on at least the foregoing drawbacks, a need exists for a patient monitoring system that relatively quickly determines blood pressure measurements without necessarily greatly disturbing a patient. Moreover, a need exists for a portable patient monitoring system with battery longevity. Accordingly, the present disclosure includes embodiments of a patient monitoring system including a gas reservoir filled with a sufficient quantity of compressed gas to inflate an inflatable cuff and a sensor to detect blood pressure data. The gas in the gas reservoir can inflate the inflatable cuff at a controlled rate, such as, for example, at an approximately constant rate. Manual and/or electronically controlled regulators and/or valves can be used to control the flow rate of the gas into and out of the inflatable cuff. In some embodiments, the regulators and/or valves can be electronically controlled using pulse-width modulation (PWM) schemes.

A patient monitor can also be included as part of the patient monitoring system. During inflation or deflation of the inflatable cuff, the patient monitor can receive the blood pressure data from the sensor and use the blood pressure data to determine output measurements responsive to the blood pressure of the wearer. The sensor can be a pressure sensor and can be used to detect pressure variations in the inflatable cuff due to inflation, deflation, and blood flow in an artery of the wearer. Alternatively, the sensor can be an auditory sensor or stethoscope. A caregiver can use the stethoscope or auditory sensor to determine blood pressure measurements without the use of the patient monitor.

For purposes of summarizing the invention, certain aspects, advantages and novel features of the invention have been described herein. Of course, it is to be understood that not necessarily all such aspects, advantages or features will be embodied in any particular embodiment of the invention.

BRIEF DESCRIPTION OF THE DRAWINGS

Various embodiments will be described hereinafter with reference to the accompanying drawings. These embodiments are illustrated and described by example only, and are not intended to limit the scope of the disclosure. In the drawings, similar elements have similar reference numerals.

FIG. 1A is an exemplary block diagram illustrating an embodiment of a patient monitoring system;

FIG. 1B is an exemplary block diagram illustrating an embodiment of gas pathways between different components of the patient monitoring system of FIG. 1A;

FIG. 2 is an exemplary system diagram illustrating an embodiment of the patient monitoring system of FIG. 1;

FIGS. 3A-3G illustrate an exemplary embodiment of a patient monitoring system configured to be worn by a user;

FIGS. 4A-4C are plot diagrams illustrating embodiments of pressure variations of an inflatable cuff associated with a wearer during blood pressure measurement; and

FIGS. 5A and 5B are flow diagrams illustrating embodiments of a process implemented by a patient monitor for measuring the blood pressure of a wearer.

FIG. 6 is a flow diagram illustrating another embodiment of a process implemented by the patient monitor for measuring blood pressure of a wearer.

FIG. 7 is a flow diagram illustrating yet another embodiment of a process implemented by the patient monitor for measuring blood pressure of a wearer.

DETAILED DESCRIPTION

A patient monitoring system advantageously includes a gas reservoir filled with sufficient quantities of compressed gas to inflate an inflatable cuff. The gas reservoir provides several advantages to the blood pressuring monitoring system, including portability, reusability, disposability, reduction in auditory noise and electrical noise, and the ability to measure blood pressure during inflation of the blood pressure cuff.

In an embodiment, the gas reservoir of the patient monitoring system inflates the inflatable cuff at an approximately constant rate with less auditory noise. By providing a quieter environment, the patient monitoring system is capable of taking blood pressure measurements without significantly disturbing the wearer. In addition, the use of the gas reservoir can significantly reduce the amount of potentially interfering electrical noise on electrical signals from one or more sensors. Furthermore, the addition of the gas reservoir allows the patient monitor to take blood pressure measurements during inflation of the inflatable cuff.

Measuring blood pressure during inflation can reduce the time required for blood pressure measurements and the amount of pressure used. In some embodiments, the patient monitoring system can measure blood pressure in 15-20 seconds or less. Furthermore, measuring blood pressure during inflation can reduce or eliminate the need to occlude a wearer's artery.

In addition, the gas reservoir of the present disclosure can be manufactured as a smaller portable patient monitor. The gas reservoir can eliminate the need for a pump and/or motor in the portable patient monitor, thereby reducing its size. In an embodiment, the gas in the gas reservoir can be used to generate electricity for the portable patient monitor, thereby reducing or eliminating the need for a battery and further reducing the size of the portable patient monitor.

In addition to the foregoing, other embodiments of the present disclosure include patient monitoring systems with canister inflation and one or more backup inflation systems. For example, in an embodiment, when the patient monitor is for whatever reason without sufficient gas to make a reliable, accurate blood pressure measurement, a motor and pump and/or inflation bulb may advantageously be used in place of the canister. In an embodiment, the foregoing backup inflation system(s) is part of the patient monitoring system and is activated when gas from the gas canister is unavailable, unwanted, insufficient, or the like. For example, in an embodiment, a user may designate which inflation system they would prefer based on, for example, proximity to power, battery use desires, gas use management, portability, emergency, surgical, other critical monitoring environments, or the like. In still further additional embodiments, the forgoing backup inflation system(s) are separate systems that connect to the monitor in place of the canister.

In an embodiment, measurements by a patient monitoring system of the present disclosure may be controlled through applications or software executing on one or more computing devices, such as a smart phone, tablet computer, portable digital devices of all types, or other computing devices or systems or combinations of the same. In an embodiment, the computing device may include modules governing the measurement frequency during periodic measurements. In an embodiment, the applications or software may include exercise related software configured to use blood pressure measurements to enhance feedback to users on a performance of the exercise, such as, for example, calories spent, heart rate trending or the like. Additionally, inputs may include type of exercise, user demographics like height, sex, age, weight or the like. Based on the inputs, the portable digital device can provide exercise recommendations, such as walking, running, cycling or other physical activities.

In still additional embodiments of the disclosure, the patient monitoring system may communicate with electronics of the canister for quality control to ensure it is an authorized canister, for canister characteristics information, such as type, pressure, size, manufacturer, or the like. Simultaneously, the monitor may communicate with electronics of the cuff and/or sensors.

In additional embodiments of the disclosure, a patient monitoring system may connect to a gas supply supplied at a premises. For example, a hospital or other caregiver environment may have pressurized gas available from connection in a room, group of rooms, beds, instruments, or the like and straightforward connection of the monitor to the gas supply may supplement or replace the canister.

In yet another embodiment, a display of a patient monitoring system may present measurement data in a manner that reduces a need for translation when used by speakers of different languages. For example, the display may include icons, numbers, colors, analog style digital gauge icons, such as a dial, gas bar or the like, audible and/or visual alarms, combinations of the same or the like to convey measurement information to a user or caregiver.

In still further embodiments, the monitor may be entirely portable and configured to mount to an arm, wrist, waist or belt harness, carried in a pocket of the like.

Various embodiments will be described hereinafter with reference to the accompanying drawings. These embodiments are illustrated and described by example only, and are not intended to be limiting.

FIG. 1 is a block diagram illustrating an embodiment of a patient monitoring system 100 for measuring blood pressure of a wearer, which may also be referred to as taking blood pressure measurements, using an inflatable cuff 104. The patient monitoring system 100 can be used to measure the blood pressure of a wearer during inflation, deflation or both. In an embodiment, the patient monitoring system 100 includes a gas reservoir 102, the inflatable cuff 104 and a patient monitor 106.

The gas reservoir 102 houses compressed gas and is operatively connected to the inflatable cuff 104 via a gas pathway. In an embodiment, a regulator 103 is in the gas pathway between the inflatable cuff 104 and reservoir 102. In an embodiment, the regulator 103 provides a desired pressure or flow in the cuff-side so long as there is sufficient pressure on the reservoir side. Thus, gas flows from the gas reservoir 102, through the regulator 103 to the bladder of the inflatable cuff 104. In one embodiment, the gas pathway is an airtight pathway constructed of any number of materials including, but not limited to, metal, plastic, cloth, combinations of the same or some other airtight material.

The gas reservoir 102 can be implemented using one or more disposable or reusable gas tanks, cylinders, bottles, canisters, or cartridges, of any number of shapes or sizes, and can be located in the same room as the wearer, or can be remotely located from the wearer, such as in a different room or even in a different building. For example, the gas reservoir 102 can include a large gas tank that remains in a stationary location. The gas reservoir 102 can be large enough to contain sufficient gas for a large number of blood pressure readings (e.g. more than 100). Furthermore, the gas reservoir 102 can store compressed gas at any number of PSI levels. For example, the gas reservoir can store compressed gas up to about 6000 PSI or more, depending on the safety conditions of the environment. Furthermore, the gas tank can be configured to supply gas to multiple inflatable cuffs 104, thereby limiting the number of gas tanks used for multiple wearers. When the pressure levels in the gas tank reach a threshold, the gas tank can either be refilled, replaced or a combination of both. For example a rotating cache of gas tanks can be used as the gas reservoir 102.

Alternatively, the gas reservoir 102 can be implemented using a small gas tank of any number of sizes. For example, the gas reservoir 102 can be implemented using a gas tank that is small enough to fit in the palm of a hand, such as a carbon dioxide (CO₂) cartridges similar to or the same as those used for paint ball guns, tire inflation, or the like. CO₂cartridges are available from a number of different manufacturers and distributors, such as the AirSource 88 Gram Pre-filled Disposable CO₂cartridge available from Crosman (Product Code: CRO-88-GRAM). The PSI levels for smaller gas tanks can also differ greatly and can store compressed gas up to about 2000 PSI or more. In one embodiment, the gas reservoir 102 is implemented using a gas tank of compressed gas at about 1000 PSI. The small gas reservoir 102 can be used where mobility is desired. For example, paramedics or first responders can carry a small gas reservoir 102 for measuring blood pressure of persons needing emergency medical care. Using the gas reservoir 102, the emergency personnel (or some other user) can measure the blood pressure of the wearer during inflation of the inflatable cuff, deflation, or a combination of the two. The measurements can be taken using a patient monitor 106, manually using a stethoscope, or other methods.

In one embodiment, a pressure regulator, or regulator 103, placed at an opening of the gas reservoir 102 controls whether gas can exit the gas reservoir and the amount of gas allowed to exit. In one embodiment, the regulator 103 is a valve. The regulator 103 can also be configured to control the rate at which gas flows to the inflatable cuff 104, as well as the pressure of the gas or PSI level. The regulator 103 can include a second regulator near the opening of the gas reservoir 102 or in the gas pathway to form a two-stage pressure regulator. Additional regulators can be added as desired. The regulator 103 and/or valve can be implemented using any number of different valves, such as a globe valve, butterfly valve, poppet valve, needle valve, etc., or any other type of valve capable of operating as a variable restriction to the gas flow. Furthermore, the regulator 103 can include a pressure gauge to identify the pressure levels of the gas exiting the gas reservoir 102 and/or in the gas pathway.

Using the regulator 103, the inflatable cuff 104 can be inflated at a controlled rate, such as, for example, an approximately constant rate or linear rate. By inflating the inflatable cuff at a controlled rate, the wearer's blood pressure can be measured during inflation and without occluding the artery. The regulator 103 can further include a wireless transmitter for communication with the patient monitor 106, which in turn may electronically control and/or monitor the flow of gas through the regulator 103. Alternatively, the regulator 103 can communicate with the patient monitor via wired communication. Additionally, the gas reservoir 102 can include a pressure gauge to monitor the remaining pressure and/or the amount of compressed gas remaining in the gas reservoir 102. The pressure gauge can communicate the pressure levels to the patient monitor 106 via wired or wireless communication, similar to the regulator 103. Once the pressure gauge indicates a threshold pressure level or gas level has been reached, the patient monitor 106 can indicate that the gas reservoir 102 should be replaced or refilled.

The gas reservoir 102 can contain any number of compressed gases to inflate the inflatable cuff 104. For example, the gas reservoir 102 can contain compressed air, carbon dioxide, nitrogen, oxygen, helium, hydrogen, etc. Any number of other gases can be used to inflate the inflatable cuff 104. Furthermore, the gas reservoir 102 may house enough gas to inflate the inflatable cuff 104 without the use of a motor or pump during the inflation. The gas reservoir 102 can be pre-filled with gas near the wearer or at a remote site away from the wearer. In one embodiment, the gas reservoir 102 is filled with gas prior to being associated with the inflatable cuff 104. Pre-filling the gas reservoir 102 prior to use can significantly reduce the ambient noise caused during inflation of the inflatable cuff 104. In addition, by using the gas reservoir 102, the electrical noise from a motor can be removed. The reduction in ambient and electrical noise and the approximately constant rate of inflation of the inflatable cuff 104 allows the patient monitor 106 to measure the wearer's blood pressure while the inflatable cuff 104 is inflating. In addition, the gas reservoir 102 can be used to quickly inflate the inflatable cuff 104 for blood pressure measurements taken during deflation of the inflatable cuff 104.

In some embodiments, multiple gas reservoirs 102 are included as part of the patient monitoring system 100. The multiple gas reservoirs 102 can be used for backup purposes or for different tasks. For example, a first gas reservoir 102 can be a large gas reservoir and can be used to supply gas to the inflatable cuff 104 when the user is stationary. A second optionally smaller gas reservoir 102 can also be provided. When the user moves away from the first gas reservoir 102, the first gas reservoir can be disconnected from the inflatable cuff 104 and the second gas reservoir 102 will supply the gas to the inflatable cuff 104. In certain embodiments, a pump may be connected to the inflatable cuff 104 and used when the user is stationary. When the user moves, the pump is disconnected and the gas reservoir 102 supplies the gas to the inflatable cuff 104.

In some embodiments the gas reservoir 102 includes an identifier that identifies the gas reservoir 102 to the patient monitor 106. The identifier can be implemented using one or more memory chips or RFIDS located on the gas reservoir and/or one or more circuit elements, such as resistors, capacitors, inductors, op-amps, etc. The identifier can include additional information regarding the gas reservoir 102, such as the type of gas reservoir, manufacturing date and/or location, storage capacity or amount of gas that the gas reservoir 102 can hold, the quantity of gas in the gas reservoir, PSI levels, usage data, expiration dates, product histories, etc.

The patient monitor 106 can use the identifier to determine whether to use the gas reservoir 102, whether the gas reservoir 102 is compatible with the patient monitor 106, or whether the reservoir 102 is from an authorized supplier. The identifier can be unique for each gas reservoir 106 or for a set of gas reservoirs 102. In some embodiments, the identifier indicates that the gas reservoir can be used with the patient monitor 106. In certain embodiments, only gas reservoirs 102 with a particular identifier are used with the patient monitor 106. Accordingly, gas reservoirs 102 that do not include the particular identifier can be rejected and/or ignored by the patient monitor 106. In an embodiment, an emergency use override may allow for measurements, or a specific number of measurements in an emergency situation, even when, for example, the identifier does not indicate an authorized supplier but is otherwise safe for use.

It is to be understood that other techniques exist for implementing the gas reservoir 102 without departing from the spirit and scope of the description. For example, the gas reservoir 102 can be implemented using the central gas line of a building, such as a hospital or other healthcare facility. Alternatively, the gas reservoir 102 can be implemented using a bulb, bladder, pump, or the like. In still further embodiments, the foregoing alternatives may serve as backup options if the reservoir 102 is empty or otherwise not functional.

The inflatable cuff 104 includes a bladder and fills with gas in a manner controlled by the patient monitor 106 or manually, and is used to at least partially obstruct the flow of blood through a wearer's artery in order to measure the wearer's blood pressure. The inflatable cuff 104 can be attached to a wearer's arm or other location, and can be inflated automatically (e.g., via intelligent cuff inflation) or manually to obtain blood pressure data. Blood pressure data can include any type of signal received from a sensor sufficiently responsive to blood pressure to provide an indicator thereof to a user. Blood pressure data can be in the form of pressure sensor data, auditory sensor data, and the like.

The inflatable cuff 104 can further include a wireless transmitter for wireless communication with the patient monitor 106. Alternatively, the inflatable cuff can include cables for sending and receiving information to and from the patient monitor 106. The inflatable cuff can receive gas from a gas reservoir 102 via a gas pathway. Furthermore, the inflatable cuff can include a release valve for releasing the gas stored in the inflatable cuff once inflated. The release valve can be actuated electronically by the patient monitor 106 or manually by a user. In some embodiments, the release valve can be used when the pressure in the inflatable cuff 104 reaches unsafe levels or when the inflatable cuff 104 has been inflated beyond a threshold period of time. In certain embodiments, the release valve can be actuated electronically using PWM signals. In some embodiments, the inflatable cuff 104 is a disposable cuff that can be discarded after a one or a few uses. In certain embodiments, the inflatable cuff 104 can be reused many times and cleaned or sterilized between uses.

A sensor 108 can be placed in close proximity to the inflatable cuff 104 to monitor the inflatable cuff 104 during inflation and deflation. Alternatively, the sensor 108 can be located in the patient monitor 106 along a gas pathway between the gas reservoir 102 and inflatable cuff 104, or at some other location where it is able to collect sufficient data for the patient monitor 106 to determine the blood pressure of the wearer.

The sensor 108 can be a pressure sensor or an auditory sensor. In one embodiment, the sensor 108 communicates signals responsive to the pressure in the inflatable cuff 104 to the patient monitor 106 via wired or wireless communication. The patient monitor uses the signal to determine a blood pressure measurement or change in blood pressure of the wearer. The patient monitor 106 can additionally use the pressure measurements to determine if the pressure in the inflatable cuff 104 is above a threshold or is at an unsafe level. If the pressure in the inflatable cuff 104 is above a threshold or is at an unsafe level, the patient monitor 106 can actuate an emergency release valve to deflate the inflatable cuff 104. In an embodiment where the sensor 108 is an auditory sensor, the sensor 108 can be used to detect Korotkoff sounds. In one embodiment, the sensor 108 comprises a stethoscope.

In an embodiment, the patient monitor 106 includes a display device 110, a user interface 112, and a microprocessor or microcontroller or combination thereof 114. The patient monitor 106 can further include a number of components implemented by the microprocessor 114 for filtering the blood pressure data received from the sensor 108 and determining the blood pressure of the wearer. The patient monitor 106 can be a dedicated device for determining blood pressure and other physiological parameters, a portable electronic device configured to execute a program or application that determines blood pressure and other physiological parameters, or can be part of a larger patient monitoring device, such as those devices described in U.S. patent application Ser. No. 09/516,110, titled “Universal/Upgrading Pulse Oximeter,” filed Mar. 1, 2000; U.S. patent application Ser. No. 14/534,827, titled “Multi-Stream Data Collection System For Noninvasive Measurement Of Blood Constituents,” filed Aug. 3, 2009; U.S. patent application Ser. No. 12/497,523, titled “Contoured Protrusion For Improving Spectroscopic Measurement Of Blood Constituents,” filed Jul. 2, 2009; U.S. patent application Ser. No. 12/882,111, titled “Spot Check Monitor Credit System,” filed Sep. 14, 2010; U.S. patent application Ser. No. 13/308,461, titled “Handheld Processing Device Including Medical Applications For Minimally And Non Invasive Glucose Measurements,” filed Nov. 30, 2011 and U.S. patent application Ser. No. 11/366,995, titled “Multiple Wavelength Sensor Equalization,” filed Mar. 1, 2006. Each of which is incorporated by reference herein.

In some embodiments, the patient monitor 106 is configured to communicate with the inflatable cuff 104 and/or the gas reservoir 102 via wired or wireless communication, such as LAN, WAN, Wi-Fi, infra-red, Bluetooth, radio wave, cellular, or the like, using any number of communication protocols. The patient monitor 106 can further be configured to determine blood pressure measurements of a wearer when the inflatable cuff 104 is being inflated with gas from the gas reservoir 102, during deflation of the inflatable cuff 104, or a combination of both. The patient monitor 106 can use the microprocessor 114, the filtering component, and blood pressure monitoring component to determine the blood pressure measurements. The blood pressure measurements determined by the patient monitor 106 can be displayed on the display 110. In addition, the display 110 can display blood pressure data and filtered blood pressure data in the form of plots of the pressure of the inflatable cuff and plots of the pressure oscillations in the inflatable cuff 104 caused by blood flowing through an artery of the wearer. Furthermore, the patient monitor 102 can calculate and the display 110 can display additional physiological parameters, such as heart rate, perfusion, oxygen saturation, respiration rate, activity information, temperature, and the like, combinations thereof or the trend of any of the above.

The user interface 112 can be used to allow a user to operate the patient monitor 106 and obtain the blood pressure measurements and/or other physiological parameters. Furthermore, the user interface 112 can allow a user to set or change any number of configuration parameters. For example, using the user interface 112, a user can determine what is displayed on the display 110, such as the blood pressure measurements during inflation and/or deflation, additional physiological parameters, the pressure plots, and/or other physiological parameters, etc. Furthermore, the user interface 112 can allow a user to set what measurements of what parameters the patient monitor 106 should take. For example, the user can set the configuration parameters to take blood pressure measurements only during inflation or deflation. Alternatively, the user can use the user interface 112 to set the configuration parameters to take blood pressure measurements during inflation and deflation and then use both measurements to determine an appropriate blood pressure. In addition, using the user interface 112, the user can determine how often the patient monitor 106 takes blood pressure measurements, or other physiological parameter measurements. The user interface 112 can further be used for any other type of configuration parameters that can be set or changed by a user. In some embodiments, the user interface 112 is implemented as an application of a portable electronic device.

In some embodiments, the patient monitor 106 monitors the use of the gas reservoir. To monitor the use of the gas reservoir 102, the patient monitor can monitor the number of times that the gas reservoir 102 is used to fill the inflatable cuff 104, the amount of time that the gas reservoir 102 is supplying gas, current pressure levels within the gas reservoir 102, and the like.

The patient monitor 106 can store usage data of the gas reservoir 102 in a memory device located on or in the gas reservoir 102. In some embodiments, the memory device is the identifier discussed previously. In certain embodiments, the memory device is located in the patient monitor 106 or some other location, and a unique identifier of the gas reservoir 102 can be used to correlate a particular gas reservoir 102 with its usage data.

Each time the gas reservoir 102 is used to inflate the inflatable cuff 104, the patient monitor 106 can update the usage data. In some embodiments, the usage data reflects a total number of instances in which the gas reservoir has been used to inflate the cuff 104. In certain embodiments, the usage data reflects the amount of time that the gas reservoir 102 has been supplying gas and the rate at which the gas has been supplied. Further embodiments can use any combination of the embodiments described herein.

Using the number of times that the gas reservoir has been used to fill the inflatable cuff 104 and other data regarding the gas reservoir 102, the patient monitor 106 can determine when the gas reservoir 102 will run out of gas and/or the number of remaining uses. In certain embodiments, the patient monitor 106 uses the storage capacity of the gas reservoir 102 and the amount of gas used to fill the inflatable cuff 104 to determine the number of times the gas reservoir can be used to fill the inflatable cuff 104 before it should be replaced. In some embodiments, the patient monitor 106 calculates the total amount of time the gas reservoir 102 is able to output gas before it should be replaced based on the storage capacity and the rate of flow of the gas. The patient monitor 106 can also account for any change to the rate of flow. Additional methods can be used to calculate whether the gas reservoir 102 should be replaced. For example, a pressure sensor can be used to determine the pressure levels within the gas reservoir 102.

When the usage data indicates that the capacity of the gas reservoir 102 is about to be (or has been) met, the patient monitor 106 can alert a user that the gas reservoir 102 should be replaced. The patient monitor 106 can alert a user by sounding an alarm, flashing a light, sending an email, text message, fax, page, or the like to a user.

In an embodiment where many canisters may be in circulation with one or more monitors, the monitor may use a canister ID to track usages for different canisters, such as, for example, the identifier. In embodiments where each canister includes accessible memory storage, the usage information stored in such memory may be updated by the monitor or canister during use.

FIG. 1B illustrates a block diagram of gas pathways between different components of the patient monitoring system 100. As described previously, the patient monitoring system 100 can include a gas reservoir 102, an inflatable cuff 104, a patient monitor (not shown), a pressure sensor 108, a flow valve 120, an emergency shutoff 122, and gas pathways 124. The gas from the gas reservoir 102 travels via the gas pathways 124 and valve 120 to the inflatable cuff 104.

The flow valve 120 can direct the gas from the gas reservoir 102 to the cuff 104 or to an exit pathway. During deflation of the cuff 104, the flow valve can direct the gas from the cuff 104 to the exit pathway. In some embodiments, the flow valve is controlled using PWM signals. The pressure sensor 108 measures the pressure within the gas pathway as well as the changes in pressure due to the blood pressure of the wearer. The emergency shutoff 122 can be used to quickly deflate the cuff 104 as desired. The components illustrated in FIG. 1B can be located in different positions. For example, the pressure sensor 108 and emergency shutoff 122 can be located on or in the cuff 104.

FIG. 2 illustrates a patient monitoring system 200 similar to the patient monitoring system 100 of FIG. 1. Similar to the patient monitoring system 100 of FIG. 1, the patient monitoring system 200 of FIG. 2 includes a gas reservoir 202, an inflatable cuff 204, a patient monitor 206, and a sensor 226 a like gas pathway between the reservoir 202 and cuff 204. In addition, the patient monitoring system 200 includes the gas pathway having a number of gas pathway segments 210, 214, 218 and valves 212, 216, 222 facilitating the movement of gas throughout the system. The gas reservoir 202, the inflatable cuff 204, the patient monitor 206, the valve 216, and the sensor 226 can communicate using wired or wireless communication. Cables 228 can be used to facilitate communication between the various components of the patient monitoring system 200. The various components can be connected to each other or connected to a central location, such as the patient monitor 206. Alternatively, the cables 228 can be removed and the patient monitor 202 can communicate with the other components of the patient monitoring system via wireless communication.

As mentioned previously with reference to FIG. 1, the gas reservoir 202 can be implemented using one or more gas tanks of any number of different sizes. In addition, the gas reservoir 202 can be located in the same room as the wearer or can be located at a remote location, such as in a different room or different building from the wearer. In such an embodiment, the gas pathway runs from the wearer to the remote location where the gas reservoir 202 is located. In addition, the gas reservoir 202 can be filled with any number of different gases prior to use with the wearer 218. In other words, the gas reservoir 202 can be filled with gas prior to installation with the other components of the patient monitoring system 200. In one embodiment, the gas reservoir 202 is filled with a compressed gas.

Furthermore, in an embodiment, the gas from the gas reservoir 202 can be used to generate electricity for the patient monitoring system 200. A small turbine can be located near the opening of the gas reservoir 202, along the gas pathway, or near an opening of the inflatable cuff 204. As the gas flows by the turbine and into the inflatable cuff 202, the turbine rotates. The rotation of the turbine can be used to generate electricity for the patient monitoring system 200. The electricity can be fed to the patient monitor 206 so that the patient monitor 206 can process received signals and determine output measurements for the blood pressure of the wearer as the inflatable cuff inflates. Another turbine can be located near the release valve 224 of the inflatable cuff 204 or the gas pathway segment 220. When the release valve 224 of the inflatable cuff 204 is opened or the valve 216 is actuated, the exiting gas causes the turbine to rotate, thereby generating electricity. The generated electricity can be fed to the patient monitor 206, allowing the patient monitor to process received signals and determine output measurements for the blood pressure of the wearer as the inflatable cuff 204 deflates.

Using the gas reservoir 202 to inflate the inflatable cuff 204 can significantly reduce the ambient noise caused by the patient monitoring system, resulting in a quieter environment for the wearer. In addition, the gas reservoir 202 can supply gas at an approximately constant pressure and rate. Thus, the patient monitoring system 200 can inflate the inflatable cuff at an approximately constant rate without the auditory and electrical interfering noise of a motor or pump, resulting in a cleaner signal for the patient monitor 206. Furthermore, by using the gas reservoir 202, the patient monitor can measure the wearer's blood pressure during inflation of the inflatable cuff 204.

By measuring the blood pressure during inflation of the inflatable cuff, the patient monitoring system 200 can measure the blood pressure in less time and using less pressure. Furthermore, measuring blood pressure during inflation of the inflatable cuff can reduce, and in some embodiments completely remove, the amount of time that the artery is occluded, allowing for more frequent blood pressure readings and reduced discomfort for the patient.

The gas reservoir 202 is operatively connected with the inflatable cuff 204 via the regulator 208, gas pathway segments 210, 214, 218 and valves 212, 216. The gas pathway and gas pathway segments 210, 214, 218 can be made of any air-tight material, such as a plastic tube, metal, cloth, combinations or the like. Gas from the gas reservoir 202 flows through the gas pathway segments 210, 214, 218 to inflate the inflatable cuff 204. In an embodiment, the regulator 208, the gas pathway segments 210, 214, 218 and the valves 212, 216, 222 control the direction and rate of gas flow throughout the patient monitoring system 200. The regulator 208, which can also be a valve, located near the opening of the gas reservoir 202 controls the pressure of the gas exiting the gas reservoir 202 and along the gas pathway segment 210. The valve 212 controls the pressure of the gas exiting gas pathway segment 210 and along gas pathway segments 214, 218 to the inflatable cuff 204. The regulator 208 and valve 212 can be configured as a two-stage pressure regulator and used to maintain an approximately constant pressure of gas entering the inflatable cuff 204. The approximately constant pressure of gas may advantageously lead to an approximately constant rate of inflation of the inflatable cuff 204. The regulator 208 and valve 212 can be configured to maintain any number of pressure levels in the gas pathway segments 210, 214, 218. In one embodiment, the regulator 208 and valve 212 are configured to maintain a pressure of approximately 6 PSI (pounds per square inch) along the gas pathway segment 214 and gas pathway segment 218.

The valve 216 located along the gas pathway segments 210, 214, 218 can be used to control the direction of the gas flow throughout the patient monitoring system 200. In an “on” configuration, the valve 216 allows the gas to pass from the gas pathway segment 214 to the gas pathway segment 218 into the inflatable cuff 204. In an “off” configuration, the valve 216 closes the gas pathway between the gas reservoir 202 and the inflatable cuff 204 and opens a gas pathway from the inflatable cuff 204 and gas pathway segment 218 to the gas pathway segment 220 and through valve 222. The valve 216 can be actuated electronically using the patient monitor 206 or manually by a user. For safety, the default position for the valve 216 can be the “off” configuration. In this way, should there be any malfunctions, the inflatable cuff 204 can deflate. In an embodiment, the valve 216 is a three-way valve. The valve 216 can be implemented in a number of different ways without departing from the spirit and scope of the description.

The valve 222 is similar in most respects to the valve 212 and can control the rate at which gas is allowed to exit the inflatable cuff 204. The valves 212, 222 can be implemented as any number of different valves, such as globe valve, butterfly valves, poppet valves, needle valves, proportional valves, etc., or any other type of valve capable of operating as a variable restriction to the gas flow. Furthermore, the valves 212, 222 can be actuated manually by a user or electronically by the patient monitor 206.

A number of alternative embodiments exist for implementing the patient monitoring system 200 without departing from the spirit and scope of the description. For example, the valve 216 can be located in the inflatable cuff 204 or nearby. In addition, the valves 216, 222 can be removed completely. In this embodiment, the patient monitor 206 can actuate the regulator 208 and/or valve 212 to inflate the inflatable cuff 204. When the inflatable cuff 204 is to be deflated, the patient monitor 206 can actuate the regulator 208 and/or valve 212 a second time, as well as actuate the release valve 224. Alternatively, two valves can be used in place of the valve 216. One valve can be used to allow gas to flow from the gas reservoir to the inflatable cuff. The second valve can be used to release gas from the inflatable cuff. The two valves can be actuated independently or at the same time. Furthermore, the two valves can be actuated electronically using the patient monitor 206 or manually by a user.

In addition, the regulator 208 and valve 212 can be implemented using any number of different configurations. For example, regulator 208 and valve 212 can be implemented as two separate devices as shown or as one single device. Alternatively, the patient monitoring system 200 can be implemented using only the regulator 208 and/or the valve 212. In addition, the regulator 208 or any of the valves 212, 216, 222 can further include a pressure gauge to identify the pressure levels of the gas. In addition, the regulator 208 and each valve 212, 216, 222 can communicate with the patient monitor 206 via wired or wireless communication.

As mentioned previously, the inflatable cuff 204 is used to at least partially obstruct an artery of a wearer to measure the wearer's blood pressure. In an embodiment, the inflatable cuff 204 partially obstructs the wearer's artery without occluding, or completely closing, the artery to determine a blood pressure measurement of the wearer.

In one embodiment, the inflatable cuff 204 includes a bladder, a release valve 224 and an attachment mechanism. The bladder contains the gas received from the gas reservoir 202, via the gas pathway and can be made of any material capable of holding gas. For example, the bladder can be made of plastic, cloth, or some other airtight material. Furthermore, the bladder can be configured to hold gas at any number of PSI levels. In one embodiment, the bladder is capable of holding gas at about 4 PSI. However, it is to be understood that the bladder can hold gas at greater than or less than about 4 PSI. An opening in the bladder allows the gas from the gas reservoir to enter exit.

The attachment mechanism allows the inflatable cuff 204 to be attached to a wearer. The attachment mechanism can be made of hook and loop type fasteners, cloth, a clip, flexible materials, water wicking materials, or other material that allows the inflatable cuff 204 to attach to a wearer. The release valve 224 can be actuated manually by a user, electronically by the patient monitor 206, or automatically based on a predefined threshold pressure level. The release valve 224 can be used to release the gas from the inflatable cuff 204 when the pressure reaches a predetermined threshold or unsafe level, or when the inflatable cuff 204 has been inflated above a threshold pressure for a predetermined amount of time.

The sensor 226 can be located on the inside of the inflatable cuff 204, at the patient monitor 206, along the gas pathway segments 210, 214, 218 or along a separate gas pathway segment, as illustrated in FIG. 2. Alternatively, the sensor 226 can be located at the wearer's ear, wrist, finger, or other location. When obtaining blood pressure data from the finger, wrist, or ear less pressure is needed to identify the blood pressure of a wearer, which increases the amount of blood pressure measurements that can be taken by the gas reservoir 202. As mentioned previously, the sensor 226 can be used to collect blood pressure data from the wearer. In an embodiment, the sensor 226 is a pressure sensor capable of measuring the pressure of the inflatable cuff 204 as the inflatable cuff 204 inflates and/or deflates. In another embodiment, the sensor 226 is an auditory sensor used to identify Korotkoff sounds as the inflatable cuff 204 inflates and/or deflates. The cables 228 can be used to communicate the information from the sensor 226 to the patient monitor 206. Alternatively, the sensor 226 can use a wireless transmitter to communicate the blood pressure data to the patient monitor 206.

As mentioned previously, the patient monitor 206 includes a display 230 capable of displaying the diastolic and systolic pressure 232 of the wearer as determined by the patient monitor 206 during inflation and/or deflation. Furthermore, the patient monitor 206 can display the blood pressure measured during inflation and deflation, thereby allowing the user to compare the values. The display 230 of the patient monitor 206 can further be configured to display pressure plots, which can include plots of the blood pressure data 236A and filtered blood pressure data 236B. The plots of the blood pressure data 236A can include the pressure of the inflatable cuff 204 over time, and the plots of the filtered blood pressure data 236B can include the pressure oscillations observed by the sensor, as will be described in greater detail below with reference to FIGS. 3A-3C. In addition, the patient monitor 206 can be configured to display additional physiological parameters 234 as further illustrated on the display device 208. These physiological parameters can include, but are not limited to, heart rate, oxygen saturation, perfusion, glucose measurements, and the like. In addition, the patient monitor 206 can include configuration parameters to control the display 230, as well as the patient monitor 206. Using the configuration parameters, a user can initiate blood pressure measurements of the wearer 218 to control the patient monitor 206.

The patient monitor can also include a user interface for setting or changing the configuration parameters. The configuration parameters can be used to set the frequency and type of blood pressure measurements taken as well as the manner in which to display the measurements. In an embodiment, a periodic or other schedule can be set to obtain measurement; for example, times of day, duration between, or the like may be used to set measurement schedules. In other embodiments, the monitor may monitor other parameters, such for example, oxygen saturations, where a predetermined change in the other parameters triggers a blood pressure measurement.

The configuration parameters can determine how often a blood pressure measurement should be taken, whether it should be taken during inflation, deflation or both. Furthermore the configuration parameters can determine how the patient monitor calculates the blood pressure measurements, such as using the inflationary blood pressure measurements, the deflationary blood pressure measurements, arbitrating between the two, or using a combination such as any a statistical combination of the two or additional measurements like, for example, past measurements. Furthermore, the configuration parameters can determine how the blood pressure measurements should be displayed. For example, the configuration parameters can dictate that only inflationary blood pressure measurements, deflationary blood pressure measurements, the more reliable measurement, or combinations thereof are to be displayed. Furthermore, the configuration parameters can determine if and how the pressure plots, and other physiological parameters are to be displayed.

In addition, the patient monitor 206 can be configured to determine blood pressure measurements while the inflatable cuff 204 is inflating and without occluding the wearer's artery. The patient monitor 206 can be configured to actuate a valve connected to the gas reservoir 202, causing gas to flow from the gas reservoir 202 to the inflatable cuff 204. As the inflatable cuff 204 inflates, the patient monitor 206 can calculate the diastolic pressure and systolic pressure of the wearer 218 using any number of techniques, as described in greater detail below with reference to FIGS. 4A and 4B. For example, the patient monitor 206 can calculate the diastolic pressure and systolic pressure by measuring oscillations of blood flow in an artery or auditory cues as the inflatable cuff 204 inflates and/or deflates. By measuring the wearer's blood pressure during inflation of the inflatable cuff, both the diastolic and systolic pressure can be determined by partially obstructing the wearer's artery and without occluding it. Once the systolic pressure is measured, the patient monitor can actuate the valve 216 or a release valve 224 on the inflatable cuff 204 to release the gas within the inflatable cuff 204.

FIGS. 3A-3G illustrate an embodiment of a patient monitoring system 300 configured to be worn by a user. FIG. 3A is a front perspective view of an embodiment of the patient monitoring system 300. The patient monitoring system 300 includes a patient monitor 302, an inflatable cuff 304, and a chamber 306 to retain a gas reservoir 308. The inflatable cuff 304 and chamber 306 can be removably attached to the patient monitor 302. The patient monitor 302, chamber 306, and gas reservoir 308 will be described in greater detail below, with reference to FIGS. 3B-3G.

The inflatable cuff 304 is similar to the inflatable cuffs described in greater detail above, with respect to FIGS. 1A, 1B, and 2. In the illustrated embodiment, the inflatable cuff 304 includes an arm band and can be wrapped around an arm of a user. The inflatable cuff 304 can include one or more attachment surfaces 326A, 326B to maintain the inflatable cuff 304 in a relatively fixed position around the arm of the user. In the illustrated embodiment, the attachment surfaces 326A, 326B are located on either side of the patient monitor 302. In some embodiments, the attachment surfaces 326A, 326B are located on one side of the patient monitor 302, or there is only one attachment surface. The attachment surfaces 326A, 326B can be made from a variety of different materials, such as, but not limited to, hook and loop type fasteners, buttons, snaps, hooks, latches, tape, or other device capable of maintaining the inflatable cuff 304 in a substantially fixed position about the user.

Although not illustrated in FIG. 3A, the patient monitoring system 300 can further include one or more sensors capable of detecting one or more physiological parameters of the user. The sensors can communicate with the patient monitor 302 via wired or wireless communication using a variety of protocols, including, but not limited to, TCP/IP, Bluetooth, ANT, ANT+, USB, Firewire, etc. For example, the patient monitoring system 300 can include one or more pressure sensors, auditory sensors, pulse oximetry sensors, thermometers, accelerometers, and/or gyroscopes. The physiological parameters detected by the various sensors can include, but are not limited to, blood pressure, heart rate, temperature, perfusion, respiration, activity rate, etc. One or more of the sensors can be located within the inflatable cuff 304 or elsewhere on the user. For example, an auditory sensor can be located on the chest of the user to collect respiration data about the user. Another auditory sensor can be located within the inflatable cuff 304 to collect blood pressure data.

FIG. 3B is a front perspective view of an embodiment of the patient monitor 302 and the chamber 306. In the illustrated embodiment, the patient monitor 302 includes a display 310, a communications link indicator 312, and user interface objects 314, 316. In some embodiments, the patient monitor 302 can further include a power monitor that determines the amount of power remaining for use by the patient monitor 302. When the patient monitor is battery-operated, the power monitor can determine the amount of time or the number of blood pressure measurements that remain before the batteries are to be replaced or recharged.

The patient monitor 302 can be a device dedicated to the measurement of physiological parameters or can be a portable electronic device configured to measure physiological parameters. In some embodiments, the patient monitor 302 is a portable electronic device, such as a smartphone, tablet, or the like, running a program or application configured to calculate physiological parameters based on signals received from the sensors.

The patient monitor 302 receives data from one or more sensors and processes the data to extract physiological parameters of the user. For example, the patient monitor 302 can receive data from a pressure and/or auditory sensor and calculate the patient's blood pressure. In some embodiments, the patient monitor 302 uses accelerometer and gyroscope data to calculate an activity level of the user.

The patient monitor 302 can also provide activity recommendations based on the physiological parameters of the user. For example, the patient monitor can use the patient's height, weight, age, sex, blood pressure readings, heart rate, etc., to recommend a physical activity such as walking, running, or cycling. Furthermore, during an activity the patient monitor 302 can provide recommendations as to whether the patient should increase or decrease their activity levels.

The display 310 is an embodiment of the display 110 described above with reference to FIG. 1A. The display 310 can be implemented using a touch screen, LCD screen, LED screen, or other type of screen and can be used to display one or more physiological parameters, plot diagrams, or user interface information, etc. The display 310 can be any number of different sizes, and in some embodiments, covers a majority of one side of the patient monitor 302. In the illustrated embodiment, the display 310 displays heart rate data 318, blood pressure data 320, 322, and a health indicator 324. However, additional physiological parameters can be displayed, such as, but not limited to, temperature, respiration data, perfusion index data, plethysmograph data, metabolism data, such as calories/hour, etc.

The health indicator 324 can be based on the heart rate data 318, blood pressure data 320, 322, other physiological parameters, or any combination thereof, and can indicate an overall well being of a user. For example, if the patient monitor 302 determines that the blood pressure data 320, 322 is normal, an arrow can point to the middle of the health indicator 324 or the health indicator 324 can be green, etc. If the patient monitor 302 determines that the blood pressure data 320, 322 is high or low, the arrow can point to the top or bottom health or the health indicator 324 can be red or blue, etc. Similarly, other physiological parameters or a combination of physiological parameters can be used by the health indicator 324.

The communication link indicator 312 can be used to indicate whether a communication link is established with one or more devices, such as the sensors, a computer, a portable electronic device, etc. The communication link indicator 312 can change colors or blink depending on the status of the communication link. For example, the communication link indicator 312 can blink during initialization, can turn green once connected, and turn red when a signal is lost or is below a threshold level.

The user interface objects 314, 316 can be implemented using hardware or software. For example, the user interface objects 314, 316 can be buttons or keys, form part of the display 310, or any combination thereof. The user interface objects 314, 316 can be used to interface with the patient monitor 302. For example, the user interface object 314 can be used to select one or more options from the patient monitor 302, such as which physiological parameters to display, how to display the physiological parameters, toggle between which sensors to use, view historical physiological parameter data, etc. In addition, the user interface objects 314, 316 can be used to determine the frequency with which blood pressure measurements should be taken. For example, using the user interface objects 314, 316 the patient monitor 302 can be configured to automatically take blood pressure measurements sequentially as determined by a user, or can be configured to take only one blood pressure measurement before requiring additional input from the user. For example, in some embodiments, by pushing or holding down a user interface object, the patient monitor 302 will automatically toggle between a single measurement mode and a sequential measurement mode. Furthermore, the user interface objects 316 can be used to scroll through one or more options displayed on the display 310. Other user interface objects can be used as desired.

With continued reference to FIG. 3B, the chamber 306 can be in physical contact with the patient monitor 302. In some embodiments, the patient monitor 302 fits into a pre-formed case, which also contains the chamber 306. In certain embodiments, the patient monitor 302 includes attachment mechanisms to connect with the chamber 306. The attachment mechanisms can include, but are not limited to, clips, screws, screw holes, bars, snaps, buttons, and the like. The gas reservoir 308 fits into the chamber 308 as illustrated and as will be described in greater detail with reference to FIG. 3C. Furthermore, the chamber 306 can be adjusted to fit different sized gas reservoirs 308.

FIG. 3C is a back perspective view of the patient monitor 302 and chamber 306. The illustrated embodiment further includes a gas reservoir interface 307 as part of the chamber 306. The gas reservoir interface 307 interacts with the gas reservoir 308 to maintain the gas reservoir within the chamber 306. The gas reservoir interface 307 can include a locking mechanism that prevents the use of unapproved or unauthorized gas reservoirs 208. The locking mechanism can be a mechanical or electronic locking mechanism.

A mechanical locking mechanism can include many forms, such as threads, a clamp, lock and key designs, etc. For example, in some embodiments, the gas reservoir interface 307 can includes threads that complement threads of the gas reservoir 308. Accordingly, the gas reservoir 308 can be screwed into the chamber 306 using the gas reservoir interface 307. In some embodiments, gas reservoirs 308 that include a different number of threads, a different design of threads, or that do not include threads will not properly interface with the gas reservoir interface 307. In certain embodiments, a clamp can act as the locking mechanism to keep the gas reservoir 308 in place. In certain embodiments, the mechanical locking mechanism can be in the form of a proprietary connector. The gas reservoir interface 307 can include a particular physical layout that is uniquely designed to interface with approved or authorized gas reservoirs 308, similar to a lock and key design.

The locking mechanism can also be implemented as an electronic locking mechanism. The electronic locking mechanism of the gas reservoir interface 307 can include an electronic interface that allows the patient monitor 302 to communicate with the gas reservoir 308. The electronic interface can include a memory chip, processor, RFID, resistor, or other circuit elements that can interface with electronics on the gas reservoir 308. Authorized or approved gas reservoirs 308 can include the circuit elements that can unlock the electronic locking mechanism of the gas reservoir interface 307 and allow the gas reservoir 308 to be used with the patient monitor 302.

The illustrated embodiment also includes an interface 330 attached to the patient monitor 302 and used to maintain the patient monitor 302 in close proximity to the inflatable cuff 304. The recess 332 of interface 330 can complement a portion of the cuff 304 to lock the patient monitor 302 in place with the cuff 304. Screws 334 can be used to maintain the interface 330 attached to the patient monitor 302.

FIGS. 3D and 3E are side perspective views of the patient monitor 302 and chamber 308. FIGS. 3F and 3G are top and bottom perspectives of the patient monitor and chamber 308, respectively. With reference to FIG. 3G, the patient monitor 302 can include an electronic interface 336, such as a USB or mini-USB port. The electronic interface 336 can be used to communicate with another electronic device, such as a computer or portable electronic device. FIG. 3G further illustrates that the chamber 306 can be rotated forwards and backwards as desired. For example, the chamber 306 can be physically attached to the patient monitor 302 via a pivot that allows the chamber 306 to swing about one or more axes. The pivot can be implemented using a hinge, ball-and-socket joint, link, pin, spring, swivel, bolt, and the like. The pivot can also include a locking mechanism that can lock the chamber 306 in a certain position with respect to the patient monitor 302. The locking mechanism can be implemented using a clamp, ratchet, pin, grooves within a link, pin, spring, or bolt, and the like. In this way, the chamber 306 can be rotated to a preferred position and then locked in place for use. For example, a user can adjust the chamber 306 so that it fits snugly against their arm, or other limb, and then lock the chamber in that position so that it stays in its position when the user moves.

As mentioned previously, the display 230, can be configured to display additional information regarding the wearer. FIGS. 4A-3C are plot diagrams illustrating embodiments of various plots that can be displayed by the display 230, 310. The plots in FIGS. 4A-3C are plot diagrams illustrating some embodiments of the pressure at the inflatable cuff 204, including the oscillations of pressure, observed by the sensor 226 during inflation and deflation.

Plot 401A is a plot diagram illustrating an embodiment of the pressure of the inflatable cuff 204 during inflation and deflation, which can also be referred to as blood pressure data. The x-axis of plot 401A represents the number of samples taken by the patient monitor 206 over time. The patient monitor 206 can be configured to take samples at any number of increments to achieve a desired data resolution. For example, the patient monitor 206 can sample the inflatable cuff every second, millisecond, microsecond, etc. Although illustrated in increments of samples, time can also be used for the x-axis 402. The y-axis 404A of plot 401A represents the pressure level, in mmHg, of the inflatable cuff 204. The line 412 represents the pressure level of the inflatable cuff 204 over time.

Prior to point 408, signals on the line 412 represent electronic noise caused by the environment or the patient monitoring system 200. At point 408, the valve 216 is actuated. The valve 216 can be actuated electronically by the patient monitor 206 or manually by a user. Once actuated, gas from the gas reservoir 202 begins to inflate the inflatable cuff 204 at a rate determined by a user electronically using the patient monitor 206 or manually using the regulator 208 and/or valve 212. In one embodiment, the inflation rate is an approximately constant rate, which leads to an approximately constant increase in pressure in the inflatable cuff. The sensor 226 reads the rise in pressure in the inflatable cuff 204, as indicated by the rise in line 412 of the plot 401A. Thus, from point 408 to point 410, the inflatable cuff is in an inflation mode and is inflating.

At point 410, the valve 216 is actuated again, ending the inflation of the inflatable cuff 204. Although illustrated at 200 mmHg, the point 410 can be located at any desired pressure level. In one embodiment, the 216 valve is actuated when the measured pressure level within the inflatable cuff 204 is greater than the expected systolic pressure of the wearer. The expected systolic pressure of the wearer can be determined by previous blood pressure measurements, historical information, clinical data from one or more wearers, or the like. In one embodiment, the point 410 changes between blood pressure measurements. For example, the inflatable cuff can be configured to inflate to 200 mmHg for the first measurement. If it is determined during the first measurement that the wearer's systolic pressure is measurably less than 200, then during the proximate measurement, the inflatable cuff 204 can be inflated to a lower pressure. Varying the pressure level to which the inflatable cuff 204 inflates can conserve gas. Likewise, if the wearer's measured systolic pressure is greater than the expected systolic pressure, the inflatable cuff 204 can be inflated to a greater pressure during the proximate measurement. Alternatively, the valve 216 can be actuated once the inflatable cuff 204 reaches any desired or predefined pressure level, such as 160 mmHg, 200 mmHg, 400 mmHg, etc.

In some embodiments, in addition to ending the inflation of the inflatable cuff, actuating the valve 216 also begins a deflation mode of the inflatable cuff. For example, actuating the valve 216 can close the gas pathway between the gas reservoir 202 and the inflatable cuff 204 and open the gas pathway between the inflatable cuff 204 and ambient air, allowing the gas to exit the inflatable cuff 204. Once the valve 216 is actuated, the inflatable cuff 204 deflates leading to a decrease in pressure within the inflatable cuff 204. Actuating the valve 216, as well as the valve 222 can be configured so that the pressure within the inflatable cuff 204 decreases at any desired rate. In one embodiment, the pressure within the inflatable cuff 204 decreases at an approximately constant rate. Additional blood pressure measurements can be taken during the deflation of the inflatable cuff 204, as described in greater detail below with reference to FIGS. 5A and 5B.

The patient monitor 206 can calculate the blood pressure of the wearer at any time during inflation and/or deflation, once it has received sufficient blood pressure data. In some embodiments, the patient monitor 206 can calculate the diastolic pressure followed by the systolic pressure during inflation of the inflatable cuff 204. In certain embodiments, the patient monitor can calculate both diastolic and systolic pressure simultaneously once the valve 216 is actuated or during inflation, once the patient monitor 206 has sufficient blood pressure data. The patient monitor 206 can alternatively wait until additional measurements are taken during the deflation of the inflatable cuff 204 before calculating the diastolic and systolic pressure. In this way, the patient monitor can compare or arbitrate the diastolic and systolic measurements during inflation and deflation of the inflatable cuff 204 to achieve greater reliability in the measurements.

With continued reference to FIG. 4A, the plot 401B is a plot diagram illustrating an embodiment of the change in pressure in the inflatable cuff 204 due to blood flow in the artery during inflation and deflation of the inflatable cuff 204. In one embodiment, the line 414 is obtained by filtering the plot 401A and normalizing the data based on the change in pressure due to the inflation and deflation of the inflatable cuff 204 and can be referred to as filtered blood pressure data. The plot 401B of the pressure oscillations due to the blood flow in the artery of the wearer, or filtered blood pressure data, can be displayed on the display 230, 310 along with the plot 401A, the blood pressure readings, and/or other physiological parameters. Similar to plot 401A, the x-axis 402 of plot 401B represents the number of samples taken by the patient monitor 206 over time. The y-axis 404B of plot 401B represents normalized changes in pressure in the inflatable cuff 204.

As illustrated in the plot 401B, when the valve 216 is actuated at point 408, the inflatable cuff 204 inflates and exerts pressure against the wearer's artery. As the inflatable cuff 204 exerts pressure against the wearer's artery, the sensor 226 is able to detect the variations in pressure in the inflatable cuff 204 due to blood flow within the artery, which are also referred to as pressure variations or pressure oscillations. The pressure oscillations are illustrated in plot 401A as small deviations or bumps in the line 412.

As further illustrated by the plot 401B, as the inflatable cuff 204 continues to inflate, the artery becomes increasingly obstructed, leading to greater pressure variations observed by the pressure sensor, which leads to greater oscillations in the line 414. With continued inflation of the inflatable cuff, the variations in pressure eventually begin to decrease as the blood flow becomes occluded. At point 410, the pressure exerted by the inflatable cuff completely occludes the artery. As mentioned previously, in one embodiment, once the artery is occluded, the valve 216 is actuated allowing the gas to exit the inflatable cuff 204 and the inflatable cuff 204 to deflate. In another embodiment, the valve 216 is actuated prior to the occlusion of the artery.

As further illustrated by the plot 401, as the inflatable cuff 204 begins to deflate, the oscillations of the pressure observed by the pressure sensor 226 again begin to increase significantly as blood flow in the artery increases. As the inflatable cuff 204 further deflates, the pressure exerted on the artery decreases leading to a decrease in pressure variation observed by the pressure sensor 226. Eventually, the inflatable cuff 204 exerts little to no pressure on the artery, and the blood flow in the artery has little to no effect on the pressure in the inflatable cuff 226. The patient monitor 206 uses the characteristics of the oscillations of pressure due to blood flow through an artery of the wearer, such as the slope of the oscillations and/or the magnitude or amplitude of the oscillations, to determine the blood pressure. The patient monitor 206 can use the blood pressure data obtained during inflation and/or deflation of the inflatable cuff to determine the blood pressure.

In one embodiment, to determine the blood pressure during inflation, the patient monitor identifies the pressure in the inflatable cuff at which the largest magnitude oscillation, also referred to as the maximum deflection point or largest amplitude oscillation, during inflation is detected. In the illustrated embodiment, the pressure monitor identifies the largest magnitude oscillation at point 430. The pressure in the inflatable cuff at which the largest magnitude oscillation during inflation is detected approximately coincides with the systolic blood pressure of the wearer. In one embodiment, the patient monitor also identifies the pressure in the inflatable cuff at which the largest slope in the oscillations prior to the largest magnitude oscillation during inflation is detected. In the illustrated embodiment, the pressure monitor identifies the largest slope in the oscillations prior to the largest magnitude oscillation at point 432. The largest slope in the oscillations prior to the largest magnitude oscillation during inflation approximately coincides with the diastolic pressure of the wearer.

In addition, the patient monitor can determine the blood pressure of the wearer during deflation. In one embodiment, to determine the blood pressure during deflation, the patient monitor identifies the largest magnitude oscillation during deflation (point 434 in the illustrated embodiment). The patient monitor further identifies the pressure in the inflatable cuff at which the largest slope in the oscillations prior to the largest magnitude oscillation during deflation is detected (point 436 in the illustrated embodiment). The largest slope in the oscillations prior to the largest magnitude oscillation during deflation approximately coincides with the systolic pressure of the wearer. The patient monitor also identifies the pressure in the inflatable cuff at which the largest slope in the oscillations after the largest magnitude oscillation during deflation (point 436 in the illustrated embodiment). The largest slope in the oscillations after the largest magnitude oscillation during approximately deflation coincides with the diastolic pressure of the wearer.

A number of alternate methods exist for determining blood pressure during inflation and deflation of the inflatable cuff. For example, during deflation the patient monitor can calculate the systolic blood pressure as the pressure at which the oscillations become detectable and the diastolic pressure as the pressure at which the oscillations are no longer detectable. Alternatively, the patient monitor can calculate the mean arterial pressure first (the pressure on the cuff at which the oscillations have the maximum amplitude). The patient monitor can then calculate the diastolic and systolic pressures based on their relationship with the mean arterial pressure. Additional methods can be used without departing from the spirit and scope of the description. For example, pressure values at locations other than the largest magnitude oscillation or maximum deflection point and largest slope can also be used.

Plots 401A and 401B further illustrate the potentially adverse effect signal noise can have on the blood pressure measurements. As illustrated, signal noise is detected at least twice in line 414 prior to inflation. The detected signal noise in at least one instance exceeds the maximum deflection point during inflation. In addition, the signal noise may also contain the largest slope prior to the maximum deflection. In either event, if the signal noise is not accounted for, the patient monitor 206 is in danger of calculating diastolic and systolic pressures of the wearer at points other than during inflation or deflation. In some embodiments, based on the amount and magnitude of signal noise detected, the patient monitor can assign confidence levels to the blood pressure measurements. Based on line 414, the patient monitor 206 can place a lower confidence level in the blood pressure measurement during inflation due to the observed signal noise.

As mentioned above, the plots 401A, 401B can both be displayed on the display 230, 310 of the patient monitor 206, 302. The plots 401A, 401B can be displayed simultaneously or consecutively. In addition the plots 401A, 401B can be displayed along with the diastolic pressure and systolic pressure as measured by the patient monitor 206. Furthermore, the measured diastolic pressure and systolic pressure during inflation can be displayed along with the measured diastolic pressure and systolic pressure during deflation. In addition, the patient monitor 206 can further display additional physiological parameters measured by the patient monitor 206.

FIGS. 4B and 4C include plot diagrams illustrating additional embodiments of the pressure of the inflatable cuff 204 during inflation and deflation. Plots 403A and 405A correspond to plot 401A, and plots 403B and 405B correspond to plot 401B. Similar to plots 401A and 401B, plots 403A, 403B, 405A, and 405B illustrate the inflation of the inflatable cuff 204 beginning at point 408 and ending at point 410. In addition the deflation of the inflatable cuff begins at point 410 in plots 403A, 403B, 405A, and 405B.

Plots 403A and 403B further illustrate signal noise being exhibited at different points throughout the lines 416 and 418. The first observed signal noise occurs near the beginning of the lines 418 and another occurs near the end. Similar to the oscillations due to blood flow in the artery, signal noise is exhibited as small displacements on the line 416 and oscillations in the line 418. As illustrated, unless accounted for, the signal noise occurring in plots 403A and 403B can have an adverse affect on blood pressure measurements due at least to their magnitude. The first detected signal noise results in the maximum deflection point prior to deflation and the last detected signal noise results in the maximum deflection point after deflation. In embodiments, where maximum deflection points are used, if inflation and deflation are not demarcated appropriately or if signal noise is not accounted for, the patient monitor 206 can erroneously determine the blood pressure measurements based on the signal noise.

The plot 403B further illustrates an example where a blood pressure measurement taken during inflation can in some instance have a higher confidence level than the blood pressure measurement taken during deflation. As mentioned previously, during inflation, the diastolic pressure can be determined as the pressure at which the largest slope in line 418 prior to the maximum deflection point during inflation occurs (point 442 in the illustrated embodiment). The systolic pressure can be calculated as the pressure at which the maximum deflection point of line 418 occurs during inflation (point 440 in the illustrated embodiment). Upon deflation, the systolic pressure is calculated as the pressure at which the largest slope in line 418 prior to the maximum deflection point (point 444 in the illustrated embodiment) during deflation occurs (point 446 in the illustrated embodiment). Similarly, the diastolic pressure is calculated as the pressure at which the largest slope in line 418 after the maximum deflection point during deflation occurs (point 448 in the illustrated embodiment). As illustrated in plot 403B, the maximum deflection point during deflation can be difficult to identify, which can make it difficult to calculate the diastolic and systolic pressure of the wearer accurately. Accordingly, the confidence placed in the blood pressure measurement during deflation can be relatively low compared to the confidence level placed in the blood pressure measurement during inflation. Accordingly, the patient monitor 204 can determine that the blood pressure measurement taken during inflation is likely more accurate. In addition, depending on the amount and magnitude of the signal noise detected, the patient monitor 206 can determine that neither blood pressure measurement reaches a threshold confidence level and that blood pressure measurements should be retaken.

Plots 405A and 405B illustrate yet another example of blood pressure measurements taken during inflation and deflation of the inflatable cuff 204. As illustrated, signal noise is detected near the beginning of lines 420 and 422, resulting in oscillations observed in line 422. As mentioned previously, if not accounted for, the signal noise can adversely affect the blood pressure measurements during inflation. However, in the line 422, the maximum deflection point prior to deflation occurs during inflation. Thus, the signal noise at the beginning of the line 422 should not affect the blood pressure measurements. Plots 405A and 405B further illustrate an example where the blood pressure measurement taken during inflation can have a similar confidence level as the confidence level of the blood pressure measurement taken during deflation. As illustrated, the line 418 exhibits a distinctive maximum amplitude during inflation (point 450 in the illustrated embodiment) and during deflation (point 454 in the illustrated embodiment). In the illustrated embodiment, the patient monitor calculates the largest slope during inflation as the slope at point 452. During deflation, the patient monitor calculates the largest slop prior to the maximum amplitude at point 456 and the largest slop following the maximum amplitude at point 458.

FIG. 5A is a flow diagram illustrating an embodiment of a process 500A for measuring blood pressure during inflation of an inflatable cuff 204. As illustrated in FIG. 5A, the process 500A begins at block 502 by actuating a valve, which allows gas to flow from a gas reservoir 202 to the inflatable cuff 204, causing the inflatable cuff 204 to inflate. The valve can be located near an opening of the gas reservoir 202, at some point along the gas pathway or at the inflatable cuff 204. In one embodiment, multiple valves 212, 216 and/or regulators 208 can be included between the gas reservoir 202 and the inflatable cuff 204. Each valve and/or regulator can be actuated prior to inflating the inflatable cuff 204. The valve(s) can be actuated manually by a user or electronically by a patient monitor 206. For example, a user can manually open the valve 216 to allow gas to flow from the gas reservoir 202 to the inflatable cuff 204. The user can open the valve in a way that allows for the inflation of the inflatable cuff 204 at an approximately constant rate of inflation. A regulator 208 can also be used to achieve the approximately constant rate of inflation. Alternatively, a patient monitor 206 in communication with the gas reservoir can actuate the valve 216, allowing the gas to flow from the gas reservoir 202 to the inflatable cuff 206. Communication from the patient monitor 206 can occur by wired or wireless communication, such as a LAN, WAN, Wi-Fi, infra-red, Bluetooth, radio wave, cellular, or the like, using any number of communication protocols.

To actuate the valve, an input to the patient monitor 206 such as a button can be used. Alternatively, the patient monitor can automatically actuate the valve once the patient monitor is turned on or based on one or more configuration parameters. For example, the patient monitor can be configured to determine the blood pressure of a wearer once every time period. The timer period can be configured as any period of time, such as 6 minutes, 15 minutes, 60 minutes, etc. In yet another embodiment, the patient monitor 206 determines if the inflatable cuff is attached to a wearer. If the patient monitor 206 determines that the inflatable cuff is attached to a wearer, the patient monitor 206 can actuate the valve at predefined time intervals. Any number of methods can be used to determine if the inflatable cuff is attached to a wearer. For example, the patient monitor 206 can determine whether the inflatable cuff is attached to a wearer using infra-red sensors, pressure sensors, capacitive touch, skin resistance, processor polling or current sensing or the like.

Once the inflatable cuff 204 is inflating, the patient monitor 206 receives blood pressure data from the sensors, as illustrated in block 504. The blood pressure data can be obtained at the inflatable cuff 204 using any number of different sensors or methods. For example, a pressure sensor can be used to identify the air pressure due to the inflation and deflation of the inflatable cuff 204. The pressure sensor can be located at the inflatable cuff, the patient monitor 206, at some point along the gas pathway, or some other location where it is capable of measuring the pressure of the inflatable cuff 204. Alternatively, an auditory sensor communicatively coupled to the patient monitor 206 can be used to detect Korotkoff sounds, similar to the method used for manual determination of blood pressure using a stethoscope.

At block 506, the patient monitor 206 filters the blood pressure data. Filtering the blood pressure data can reduce the effects of, or completely remove, environmental noise and/or the electrical noise found within the patient monitoring system. Furthermore, during filtering, the patient monitor 206 can normalize the blood pressure data to account for the changes in pressure due to the inflation and deflation of the inflatable cuff. In one embodiment, after filtering the blood pressure data, only the pressure oscillations in the inflatable cuff 204 due to blood flow in an artery of the wearer remain, and in some instances signal noise. Upon filtering the blood pressure data, the patient monitor 206 can determine the blood pressure of the wearer, as illustrated in block 508.

The patient monitor 206 can determine the blood pressure using any number of different methods as described above with reference to FIGS. 4A-3C. For example, the patient monitor 206 can determine the blood pressure of the wearer using the slopes and/or amplitude of the pressure oscillations, the mean arterial pressure, and/or the Korotkoff sounds.

Once the patient monitor 206 determines the blood pressure of the wearer, the patient monitor 206 can actuate a valve to stop gases from flowing from the gas reservoir to the inflatable cuff, as illustrated in block 510. In one embodiment, the valve is a three-way valve 216 and actuating the valve to stop the gases from flowing from the gas reservoir to the inflatable cuff also opens the gas pathway segment 220 to release the gas from the inflatable cuff.

Fewer, more, or different blocks can be added to the process 500A without departing from the spirit and scope of the description. For example, the patient monitor 206 can filter the blood pressure data to determine the diastolic pressure first. As the diastolic pressure is being calculated, the patient monitor 206 can continue receiving and filtering the blood pressure data to determine the systolic pressure. In an embodiment, the patient monitor can determine the blood pressure without filtering the blood pressure data. In addition, a user can determine the blood pressure measurements without the use of the patient monitor 206. In an embodiment, a user using a stethoscope can determine the diastolic and systolic pressure during inflation of the inflatable cuff without filtering the blood pressure data.

As mentioned previously, by measuring the blood pressure during inflation of the inflatable cuff 204, the blood pressure of the wearer can be measured in less time and using less pressure. Furthermore, because the artery is occluded for less time, or not occluded at all, the blood pressure can be measured more frequently.

FIG. 5B illustrates a flow diagram of a process 500B for measuring blood pressure during deflation of an inflatable cuff. At block 550, the inflatable cuff 204 is inflated. In one embodiment, the inflatable cuff 204 is inflated using gas from a gas reservoir 202. Using the gas from the gas reservoir 202, the inflatable cuff 204 can be inflated very quickly leading to a relatively short wait time before blood pressure measurements can be taken.

As the inflatable cuff 204 inflates, the patient monitor determines whether a threshold pressure has been reached, as illustrated in block 552. The threshold pressure can be any pressure level and can vary between blood pressure measurements. Furthermore, the threshold pressure can be determined based on previous blood pressure measurements, historical information, clinical data from one or more wearers, or the like. In one embodiment, the threshold pressure is above an expected systolic pressure of the wearer. In another embodiment, the threshold pressure is above an expected occlusion pressure or the pressure at which the artery is occluded. The inflation can be initiated in a manner similar to that described above with reference to FIG. 5A. If the patient monitor 206 determines that the threshold pressure has not been reached, the inflatable cuff 204 continues to inflate. However, if the patient monitor 206 determines that the threshold pressure has been reached, the process moves to block 554.

At block 554, the patient monitor 206 actuates the valve to initiate deflation of the inflatable cuff 206. In one embodiment, the valve is a three-way valve similar to valve 216 of FIG. 2, such that the inflation of the inflatable cuff 204 ends at the same time deflation begins. Once the deflation of the inflatable cuff 204 begins, the process moves to block 556 and the patient monitor receives blood pressure data, filters the blood pressure data 558, and determines blood pressure 560. Greater detail regarding receiving blood pressure data 556, filtering the blood pressure data 558 and determining blood pressure is described above with reference to blocks 504-408 of FIG. 5A.

Fewer, more, or different blocks can be added to the process 500B without departing from the spirit and scope of the description. For example, the patient monitor 206 can determine the systolic pressure prior to receiving the blood pressure data or filtering the blood pressure data to determine the diastolic pressure. In addition, the process 500B can be implemented without the use of the patient monitor 206. For example, a user can receive blood pressure data via a stethoscope. The user can determine the blood pressure of the wearer using Korotkoff sounds, and can also determine the blood pressure of the wearer without filtering the blood pressure data. Furthermore, process 500A and 500B can be combined and measurements taken during inflation and deflation of the inflatable cuff. Furthermore, the measurements taken during deflation of the inflatable cuff can be used to verify the blood pressure readings taken during inflation of the inflatable cuff 204.

FIG. 6 is a flow diagram illustrating another embodiment of a process 600 implemented by the patient monitor for measuring blood pressure of a wearer. FIG. 6 is similar in many respects to FIGS. 5A and 5B. For example, blocks 602-508 of FIG. 6 correspond to blocks 502-408 of FIG. 5A, respectively. Furthermore, blocks 614-520 correspond to blocks 554-460 of FIG. 5B, respectively.

As described above with reference to FIG. 5A and illustrated in blocks 602-508, the patient monitor 206 actuates a valve to initiate inflation, receives blood pressure data during inflation, filters the blood pressure data, and determines the blood pressure of the wearer. Upon determining the blood pressure of the wearer, the patient monitor assigns a confidence level to the blood pressure measurements, as illustrated in block 610. The confidence level assigned can be determined in any number of ways. For example, based on the amount and magnitude of the noise observed in the blood pressure data, the patient monitor can assign the confidence level. Alternatively, if an anomaly in the blood pressure data is detected or if the blood pressure data deviates beyond a threshold level a lower confidence level can be assigned to the blood pressure measurements. In an embodiment, prior measurements or other expectations or trend information may be used to determine confidence levels.

At determination block 612, the patient monitor 206 determines if the confidence level assigned to the inflationary blood pressure measurements are above a threshold confidence level. The threshold confidence level can be determined based on previous blood pressure measurements, historical information, clinical data from one or more wearers, or the like. If the confidence level assigned to the blood pressure measurements during inflation exceeds the threshold confidence level, the patient monitor 206 outputs the inflationary blood pressure measurements, as illustrated in block 628. The inflationary blood pressure measurements can be output to a display, a printer, another patient monitor, etc. Once output, the patient monitor 206 can actuate a valve to deflate the inflatable cuff 204 at a rate greater than would be used if the blood pressure measurements were taken during deflation. Alternatively, the patient monitor 206 can deflate the inflatable cuff 204 at the same rate as when blood pressure measurements taken during deflation.

If on the other hand, the confidence level assigned to the inflationary blood pressure measurements is less than the threshold confidence level, then the patient monitor can actuate the valve to initiate deflation of the inflatable cuff, as illustrated in block 614. As blocks 614-520 correspond to blocks 554-460 of FIG. 5B, additional details with respect to blocks 614-520 are provided above with reference to FIG. 5B.

Upon determining the blood pressure during deflation, the patient monitor 206 can assign a confidence level to the deflationary blood pressure measurements, as illustrated in block 622 and described in greater detail above with reference to block 610. Upon assigning the confidence level to the deflationary blood pressure measurements, the patient monitor 206 determines if the confidence level exceeds a threshold confidence, as illustrated in determination block 624, similar to the determination made in block 612. If the patient monitor 206 determines that the confidence level assigned to the deflationary blood pressure measurements does not exceed the confidence threshold, the patient monitor 206 can output an error, as illustrated in block 626. The error can indicate that neither the inflationary blood pressure measurements nor the deflationary blood pressure measurements exceeded the confidence threshold. In addition, the patient monitor 206 can recommend that additional blood pressure measurements be taken.

If on the other hand, the patient monitor determines that the confidence level assigned to the deflationary blood pressure measurements exceeds the confidence threshold, the patient monitor outputs the deflationary blood pressure measurements, as shown in block 628.

Fewer, more, or different blocks can be added to the process 600 without departing from the spirit and scope of the description. For example, in an embodiment, the patient monitor 206 automatically returns to step 602 upon outputting the error or determining that the confidence level did not exceed the confidence threshold, and repeats the process 600. In yet another embodiment, the patient monitor 206 outputs the error as well as the blood pressure measurements having the highest confidence level.

FIG. 7 is a flow diagram illustrating yet another embodiment of a process 700 implemented by the patient monitor 206 for measuring blood pressure of a wearer. At block 702, the patient monitor 206 receives configuration parameters. The configuration parameters can be set by a user, another patient monitor, or preset. The configuration parameters can include when to measure blood pressure, how to calculate the diastolic and systolic blood pressure, what measurements to display, confidence thresholds, etc. For example the configuration parameters can include whether to take blood pressure measurements during inflation, deflation, or both. In addition, the configuration parameters can include information regarding what process to use to determine the blood pressure measurements. For example, the patient monitor can determine the blood pressure measurements using the measured arterial pressure, the slopes of the pressure oscillations, maximum deflection points of the filtered blood pressure data, or other criteria. The configuration parameters can also include the confidence level to be used in determining whether the blood pressure measurements should be accepted. Furthermore, the configuration parameters can include what blood pressure measurements are to be output and how to determine which blood pressure measurements to output. For example, the configuration parameters can dictate that only blood pressure measurements having a confidence level greater than a threshold are to be output, or that the blood pressure measurements having the highest threshold are to be output. Additionally, the configuration parameters can dictate that both blood pressure measurements, average blood pressure measurements, and the like are to be output. Furthermore, the configuration parameters can include the frequency with which the blood pressure measurements are to be taken.

At block 704, the patient monitor initiates inflation based on the received configuration parameters. For example, the configuration parameters can dictate the rate at which the inflatable cuff 204 is to be inflated using the gas reservoir 202. In an embodiment, the inflatable cuff 204 is inflated at an approximately constant rate. In another embodiment, the inflatable cuff is not inflated at an approximately constant rate. In an embodiment, the inflatable cuff 204 is inflated in a relatively short amount of time or at a very high rate of inflation. In another embodiment, the inflatable cuff 204 is inflated more slowly.

At block 706 the inflationary blood pressure measurements are determined by the patient monitor 706 based on the configuration parameters. The configuration parameters can dictate whether and what method to use in determining the inflationary blood pressure measurements. Furthermore, the configuration parameters can dictate whether the blood pressure data is filtered and how. In an embodiment, the configuration parameters dictate that the inflationary blood pressure measurements are not to be taken based on the inflation rate. In another embodiment, the patient monitor determines the inflationary blood pressure measurements based on the slope and magnitude of the oscillations of the filtered blood pressure data during inflation based on the configuration parameters. In addition, the patient monitor can set confidence levels and perform other operations based on the configuration parameters.

Upon determining the inflationary blood pressure measurements, the patient monitor initiates deflation of the inflatable cuff 204 based on the configuration parameters. The configuration parameters can dictate the time and rate at which the inflatable cuff 204 deflates. For example, the configuration parameters can dictate a threshold pressure that when reached initiates the deflation. The threshold pressure can be based on personal information of the wearer or general safety levels. In an embodiment, the patient monitor initiates deflation based on a threshold pressure being reached for a predefined period of time based on the configuration parameters. In another embodiment, the patient monitor initiates deflation once the inflationary blood pressure measurements are taken.

Upon initiating deflation, the patient monitor determines deflationary blood pressure measurements based on one or more configuration parameters, as illustrated in block 710. As discussed previously, with reference to block 706 the configuration parameters can include any number of parameters that determine if and how the deflationary blood pressure measurements are taken, as well as if and how the blood pressure data is filtered. In addition, the patient monitor can set confidence levels and perform other operations based on the configuration parameters.

Upon determining the deflationary blood pressure measurements, the patient monitor arbitrates blood pressure measurements based on the configuration parameters. The patient monitor can arbitrate the blood pressure measurements based on any number of configuration parameters. For example, the patient monitor can arbitrate the blood pressure measurements based on the highest confidence level or whether a threshold confidence level was reached. Furthermore, the patient monitor can arbitrate based on expected values, previous values, averages or the like. Alternatively, the patient monitor can select both the inflationary and deflationary blood pressure measurements.

At block 714, the patient monitor outputs the results of the arbitration based on the configuration parameters. The output can include the inflationary blood pressure measurements, the deflationary blood pressure measurements, both or a combination of the two. The output can further include additional information, such as inflation rate, deflation rate, average blood pressure measurements depending on whether they were determined during inflation or deflation, etc.

Fewer, more, or different blocks can be added to the process 700 without departing from the spirit and scope of the description. For example, based on the blood pressure measurements, the configuration parameters can be changed and the process 700 can begin again.

Depending on the embodiment, certain acts, events, or functions of any of the methods described herein can be performed in a different sequence, can be added, merged, or left out all together (e.g., not all described acts or events are necessary for the practice of the method). Moreover, in certain embodiments, acts or events can be performed concurrently, e.g., through multi-threaded processing, interrupt processing, or multiple processors, rather than sequentially.

The various illustrative logical blocks, modules, circuits, and algorithm steps described in connection with the embodiments disclosed herein can be implemented as electronic hardware, computer software, or combinations of both. To clearly illustrate this interchangeability of hardware and software, various illustrative components, blocks, modules, circuits, and steps have been described above generally in terms of their functionality. Whether such functionality is implemented as hardware or software depends upon the particular application and design constraints imposed on the overall system. The described functionality can be implemented in varying ways for each particular application, but such implementation decisions should not be interpreted as causing a departure from the scope of the disclosure.

The various illustrative logical blocks, modules, and circuits described in connection with the embodiments disclosed herein can be implemented or performed with a general purpose processor, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA) or other programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof designed to perform the functions described herein. A general purpose processor can be a microprocessor, but in the alternative, the processor can be any conventional processor, controller, microcontroller, or state machine. A processor can also be implemented as a combination of computing devices, e.g., a combination of a DSP and a microprocessor, a plurality of microprocessors, one or more microprocessors in conjunction with a DSP core, or any other such configuration.

The steps of a method or algorithm described in connection with the embodiments disclosed herein can be embodied directly in hardware, in a software module executed by a processor, or in a combination of the two. A software module can reside in RAM memory, flash memory, ROM memory, EPROM memory, EEPROM memory, registers, hard disk, a removable disk, a CD-ROM, or any other form of storage medium known in the art. An exemplary storage medium is coupled to the processor such the processor can read information from, and write information to, the storage medium. In the alternative, the storage medium can be integral to the processor. The processor and the storage medium can reside in an ASIC. The ASIC can reside in a user terminal. In the alternative, the processor and the storage medium can reside as discrete components in a user terminal.

Conditional language used herein, such as, among others, “can,” “could,” “might,” “may,” “e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements and/or steps. Thus, such conditional language is not generally intended to imply that features, elements and/or steps are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without author input or prompting, whether these features, elements and/or steps are included or are to be performed in any particular embodiment.

While the above detailed description has shown, described, and pointed out novel features as applied to various embodiments, it will be understood that various omissions, substitutions, and changes in the form and details of the device or process illustrated can be made without departing from the spirit of the disclosure. As will be recognized, certain embodiments of the inventions described herein can be embodied within a form that does not provide all of the features and benefits set forth herein, as some features can be used or practiced separately from others. The scope of the inventions is indicated by the appended claims rather than by the foregoing description. All changes which come within the meaning and range of equivalency of the claims are to be embraced within their scope.

Claims

1. A method of determining one or more blood pressure measurements, the method comprising: receiving, by a patient monitor in communication with an inflatable cuff configured to encompass a limb of a patient, a set of inflatable cuff configuration parameters;determining, by a hardware processor of the patient monitor, a first blood pressure of the patient based at least in part on an inflated pressure inside the inflatable cuff;assigning, by the hardware processor of the patient monitor, a confidence level to the first blood pressure based on the inflatable cuff configuration parameters;determining, by the hardware processor of the patient monitor, whether the confidence level satisfies a threshold confidence level; andbased at least in part on a determination that the confidence level does not satisfy the threshold confidence level: determining, by the hardware processor patient monitor, a second blood pressure of the patient based at least in part on a deflated pressure inside the inflatable cuff, andcausing a display to display at least one of the first blood pressure or the second blood pressure.
2. The method of claim 1, wherein the inflated pressure comprises pressure inside the inflatable cuff during inflation.
3. The method of claim 1, wherein the deflated pressure comprises pressure inside the inflatable cuff during deflation.
4. The method of claim 1, wherein said determining the first blood pressure comprises: inflating the inflatable cuff;receiving a first data signal indicative of the inflated pressure inside the inflatable cuff;filtering the first data signal;identifying a maximum magnitude of the filtered first data signal; andassociating a pressure of the inflatable cuff at the identified maximum magnitude with a first systolic pressure.
5. The method of claim 1, wherein said determining the second blood pressure comprises: deflating the inflatable cuff;receiving a second data signal indicative of the inflated pressure inside the inflatable cuff;filtering the second data signal;identifying a maximum magnitude of the filtered second data signal during the deflation of the inflatable cuff, a maximum slope of the filtered second data signal prior to the maximum magnitude, and a maximum slope of the filtered second data signal following the maximum magnitude; andassociating a pressure of the inflatable cuff at the identified maximum slope of the filtered second signal prior to the maximum magnitude with a second systolic pressure.
6. The method of claim 1, wherein the inflatable cuff is configured to inflate using a replaceable gas reservoir or a portable inflation system.
7. The method of claim 6, further comprising: determining whether pressure within the replaceable gas reservoir satisfies a threshold pressure level; andupon determining the replaceable gas reservoir does not satisfy the threshold pressure level, causing the display to display a notification.
8. The method of claim 6, further comprising causing the display to display a waveform of at least one of a first data signal associated with the first blood pressure or a second data signal associated with the second blood pressure.
9. The method of claim 6, further comprising determining the confidence level of the first blood pressure based on an amount and magnitude of noise observed in a first data signal associated with the first blood pressure.
10. The method of claim 6, further comprising communicating with electronics of the replaceable gas reservoir.
11. The method of claim 10, wherein the electronics indicate whether the replaceable gas reservoir is authorized.
12. The method of claim 10, wherein the electronics associated with the gas reservoir indicate reservoir characteristics.
13. The method of claim 10, wherein the electronics indicate usage of the replaceable gas reservoir.
14. The method of claim 13, wherein updated data responsive to usage of the replaceable gas reservoir is written to the electronics of the replaceable gas reservoir.
15. A method of determining one or more blood pressure measurements, the method comprising: receiving, by a processor, one or more inflatable cuff configuration parameters;determining a first blood pressure during inflation of an inflatable cuff configured to encompass a limb of a monitored patient;assigning a confidence level, by the processor, to the first blood pressure based at least in part on the one or more configuration parameters;based at least in part on a determination that the confidence level does not satisfy a threshold confidence level: determining a second blood pressure during deflation of the inflatable cuff, andcausing a display to display at least one of the first blood pressure or the second blood pressure.
16. The method of claim 15, further comprising inflating the inflatable cuff using a replaceable gas reservoir or a portable inflation system.
17. The method of claim 16, further comprising communicating with electronics of the replaceable gas reservoir.

US Referenced Citations (1263)

Number	Name	Date	Kind
2717100	Engelder	Sep 1955	A
2974503	Newton	Mar 1961	A
3316395	Lavin	Apr 1967	A
3316396	Trott et al.	Apr 1967	A
4163290	Sutherlin et al.	Jul 1979	A
4305059	Benton	Dec 1981	A
4491725	Pritchard	Jan 1985	A
4800892	Perry et al.	Jan 1989	A
4800982	Perry et al.	Jan 1989	A
4889132	Hutcheson et al.	Dec 1989	A
4960128	Gordon et al.	Oct 1990	A
4964408	Hink et al.	Oct 1990	A
4973024	Homma	Nov 1990	A
5041187	Hink et al.	Aug 1991	A
5069213	Hink et al.	Dec 1991	A
5163438	Gordon et al.	Nov 1992	A
5234015	Fumino	Aug 1993	A
5319355	Russek	Jun 1994	A
5337744	Branigan	Aug 1994	A
5341805	Stavridi et al.	Aug 1994	A
D353195	Savage et al.	Dec 1994	S
D353196	Savage et al.	Dec 1994	S
5377676	Vari et al.	Jan 1995	A
5392781	Phillipps et al.	Feb 1995	A
D359546	Savage et al.	Jun 1995	S
5431170	Mathews	Jul 1995	A
5436499	Namavar et al.	Jul 1995	A
D361840	Savage et al.	Aug 1995	S
D362063	Savage et al.	Sep 1995	S
5449379	Hadtke	Sep 1995	A
5452717	Branigan et al.	Sep 1995	A
D363120	Savage et al.	Oct 1995	S
5456252	Vari et al.	Oct 1995	A
5479934	Imran	Jan 1996	A
5482036	Diab et al.	Jan 1996	A
5490505	Diab et al.	Feb 1996	A
5494043	O'Sullivan et al.	Feb 1996	A
5533511	Kaspari et al.	Jul 1996	A
5534851	Russek	Jul 1996	A
5560366	Harada et al.	Oct 1996	A
5561275	Savage et al.	Oct 1996	A
5562002	Lalin	Oct 1996	A
5590649	Caro et al.	Jan 1997	A
5590662	Hersh	Jan 1997	A
5590696	Phillips et al.	Jan 1997	A
5602924	Durand et al.	Feb 1997	A
5632272	Diab et al.	May 1997	A
5638816	Kiani-Azarbayjany et al.	Jun 1997	A
5638818	Diab et al.	Jun 1997	A
5645440	Tobler et al.	Jul 1997	A
5671914	Kalkhoran et al.	Sep 1997	A
5685299	Diab et al.	Nov 1997	A
5726440	Kalkhoran et al.	Mar 1998	A
D393830	Tobler et al.	Apr 1998	S
5743262	Lepper, Jr. et al.	Apr 1998	A
5747806	Khalil et al.	May 1998	A
5750994	Schlager	May 1998	A
5758644	Diab et al.	Jun 1998	A
5760910	Lepper, Jr. et al.	Jun 1998	A
5769785	Diab et al.	Jun 1998	A
5782757	Diab et al.	Jul 1998	A
5785659	Caro et al.	Jul 1998	A
5791347	Flaherty et al.	Aug 1998	A
5810734	Caro et al.	Sep 1998	A
5823950	Diab et al.	Oct 1998	A
5830131	Caro et al.	Nov 1998	A
5833618	Caro et al.	Nov 1998	A
5860919	Kiani-Azarbayjany et al.	Jan 1999	A
5890929	Mills et al.	Apr 1999	A
5904654	Wohltmann et al.	May 1999	A
5919134	Diab	Jul 1999	A
5934925	Tobler et al.	Aug 1999	A
5940182	Lepper, Jr. et al.	Aug 1999	A
5987343	Kinast	Nov 1999	A
5995855	Kiani et al.	Nov 1999	A
5997343	Mills et al.	Dec 1999	A
6002952	Diab et al.	Dec 1999	A
6010937	Karam et al.	Jan 2000	A
6011986	Diab et al.	Jan 2000	A
6027452	Flaherty et al.	Feb 2000	A
6036642	Diab et al.	Mar 2000	A
6040578	Malin et al.	Mar 2000	A
6045509	Caro et al.	Apr 2000	A
6066204	Haven	May 2000	A
6067462	Diab et al.	May 2000	A
6081735	Diab et al.	Jun 2000	A
6088607	Diab et al.	Jul 2000	A
6110522	Lepper, Jr. et al.	Aug 2000	A
6115673	Malin et al.	Sep 2000	A
6124597	Shehada et al.	Sep 2000	A
6128521	Marro et al.	Oct 2000	A
6129675	Jay	Oct 2000	A
6144868	Parker	Nov 2000	A
6151516	Kiani-Azarbayjany et al.	Nov 2000	A
6152754	Gerhardt et al.	Nov 2000	A
6157850	Diab et al.	Dec 2000	A
6165005	Mills et al.	Dec 2000	A
6184521	Coffin, IV et al.	Feb 2001	B1
6206830	Diab et al.	Mar 2001	B1
6229856	Diab et al.	May 2001	B1
6232609	Snyder et al.	May 2001	B1
6236872	Diab et al.	May 2001	B1
6241683	Macklem et al.	Jun 2001	B1
6253097	Aronow et al.	Jun 2001	B1
6255708	Sudharsanan et al.	Jul 2001	B1
6256523	Diab et al.	Jul 2001	B1
6263222	Diab et al.	Jul 2001	B1
6278522	Lepper, Jr. et al.	Aug 2001	B1
6280213	Tobler et al.	Aug 2001	B1
6280381	Malin et al.	Aug 2001	B1
6285896	Tobler et al.	Sep 2001	B1
6301493	Marro et al.	Oct 2001	B1
6308089	von der Ruhr et al.	Oct 2001	B1
6317627	Ennen et al.	Nov 2001	B1
6321100	Parker	Nov 2001	B1
6325761	Jay	Dec 2001	B1
6328280	Davidson	Dec 2001	B1
6334065	Al-Ali et al.	Dec 2001	B1
6336901	Itonaga et al.	Jan 2002	B1
6343224	Parker	Jan 2002	B1
6349228	Kiani et al.	Feb 2002	B1
6360114	Diab et al.	Mar 2002	B1
6368283	Xu et al.	Apr 2002	B1
6371921	Caro et al.	Apr 2002	B1
6377829	Al-Ali	Apr 2002	B1
6388240	Schulz et al.	May 2002	B2
6397091	Diab et al.	May 2002	B2
6405943	Stadnyk	Jun 2002	B1
6411373	Garside et al.	Jun 2002	B1
6415167	Blank et al.	Jul 2002	B1
6420186	Berger et al.	Jul 2002	B1
6430437	Marro	Aug 2002	B1
6430525	Weber et al.	Aug 2002	B1
6463311	Diab	Oct 2002	B1
6470199	Kopotic et al.	Oct 2002	B1
6487429	Hockersmith et al.	Nov 2002	B2
6501975	Diab et al.	Dec 2002	B2
6505059	Kollias et al.	Jan 2003	B1
6515273	Al-Ali	Feb 2003	B2
6519487	Parker	Feb 2003	B1
6525386	Mills et al.	Feb 2003	B1
6526300	Kiani et al.	Feb 2003	B1
6534012	Hazen et al.	Mar 2003	B1
6541756	Schulz et al.	Apr 2003	B2
6542764	Al-Ali et al.	Apr 2003	B1
6543444	Lewis	Apr 2003	B1
6565524	Itonaga et al.	May 2003	B1
6580086	Schulz et al.	Jun 2003	B1
6584336	Ali et al.	Jun 2003	B1
6587196	Stippick et al.	Jul 2003	B1
6587199	Luu	Jul 2003	B1
6595316	Cybulski et al.	Jul 2003	B2
6597932	Tian et al.	Jul 2003	B2
6597933	Kiani et al.	Jul 2003	B2
6606511	Ali et al.	Aug 2003	B1
6632181	Flaherty et al.	Oct 2003	B2
6635559	Greenwald et al.	Oct 2003	B2
6639668	Trepagnier	Oct 2003	B1
6640116	Diab	Oct 2003	B2
6640117	Makarewicz et al.	Oct 2003	B2
6643530	Diab et al.	Nov 2003	B2
6650917	Diab et al.	Nov 2003	B2
6654624	Diab et al.	Nov 2003	B2
6658276	Kiani et al.	Dec 2003	B2
6661161	Lanzo et al.	Dec 2003	B1
6671531	Al-Ali	Dec 2003	B2
6678543	Diab et al.	Jan 2004	B2
6684090	Ali et al.	Jan 2004	B2
6684091	Parker	Jan 2004	B2
6697656	Al-Ali	Feb 2004	B1
6697657	Shehada et al.	Feb 2004	B1
6697658	Al-Ali	Feb 2004	B2
6697878	Imai	Feb 2004	B1
RE38476	Diab et al.	Mar 2004	E
6699194	Diab et al.	Mar 2004	B1
6714804	Al-Ali	Mar 2004	B2
RE38492	Diab et al.	Apr 2004	E
6721582	Trepagnier	Apr 2004	B2
6721585	Parker	Apr 2004	B1
6725075	Al-Ali	Apr 2004	B2
6728560	Kollias et al.	Apr 2004	B2
6735459	Parker	May 2004	B2
6738652	Mattu et al.	May 2004	B2
6745060	Diab et al.	Jun 2004	B2
6760607	Al-Ali	Jul 2004	B2
6770028	Ali et al.	Aug 2004	B1
6771994	Kiani et al.	Aug 2004	B2
6788965	Ruchti et al.	Sep 2004	B2
6792300	Diab et al.	Sep 2004	B1
6813511	Diab et al.	Nov 2004	B2
6816241	Grubisic	Nov 2004	B2
6816741	Diab	Nov 2004	B2
6822564	Al-Ali	Nov 2004	B2
6826419	Diab et al.	Nov 2004	B2
6830711	Mills et al.	Dec 2004	B2
6843465	Scott	Jan 2005	B1
6850787	Weber et al.	Feb 2005	B2
6850788	Al-Ali	Feb 2005	B2
6852083	Caro et al.	Feb 2005	B2
6861639	Al-Ali	Mar 2005	B2
6876931	Lorenz et al.	Apr 2005	B2
6898452	Al-Ali et al.	May 2005	B2
6920345	Al-Ali et al.	Jul 2005	B2
6931268	Kiani-Azarbayjany et al.	Aug 2005	B1
6934570	Kiani et al.	Aug 2005	B2
6939305	Flaherty et al.	Sep 2005	B2
6943348	Coffin, IV	Sep 2005	B1
6950687	Al-Ali	Sep 2005	B2
6956649	Acosta et al.	Oct 2005	B2
6961598	Diab	Nov 2005	B2
6970792	Diab	Nov 2005	B1
6979812	Al-Ali	Dec 2005	B2
6985764	Mason et al.	Jan 2006	B2
6988992	Just et al.	Jan 2006	B2
6990364	Ruchti et al.	Jan 2006	B2
6993371	Kiani et al.	Jan 2006	B2
6996427	Ali et al.	Feb 2006	B2
6997878	Inagaki et al.	Feb 2006	B2
6998247	Monfre et al.	Feb 2006	B2
6999904	Weber et al.	Feb 2006	B2
7003338	Weber et al.	Feb 2006	B2
7003339	Diab et al.	Feb 2006	B2
7015451	Dalke et al.	Mar 2006	B2
7024233	Ali et al.	Apr 2006	B2
7027849	Al-Ali	Apr 2006	B2
7030749	Al-Ali	Apr 2006	B2
7039449	Al-Ali	May 2006	B2
7041060	Flaherty et al.	May 2006	B2
7044918	Diab	May 2006	B2
7048687	Reuss et al.	May 2006	B1
7067893	Mills et al.	Jun 2006	B2
D526719	Richie, Jr. et al.	Aug 2006	S
7096052	Mason et al.	Aug 2006	B2
7096054	Abdul-Hafiz et al.	Aug 2006	B2
D529616	Deros et al.	Oct 2006	S
7132641	Schulz et al.	Nov 2006	B2
7133710	Acosta et al.	Nov 2006	B2
7142901	Kiani et al.	Nov 2006	B2
7149561	Diab	Dec 2006	B2
7153269	Blansett	Dec 2006	B1
7166076	Poliac et al.	Jan 2007	B2
7186218	Hersh et al.	Mar 2007	B2
7186966	Al-Ali	Mar 2007	B2
7190261	Al-Ali	Mar 2007	B2
7215984	Diab et al.	May 2007	B2
7215986	Diab et al.	May 2007	B2
7221971	Diab et al.	May 2007	B2
7225006	Al-Ali et al.	May 2007	B2
7225007	Al-Ali et al.	May 2007	B2
RE39672	Shehada et al.	Jun 2007	E
7239905	Kiani-Azarbayjany et al.	Jul 2007	B2
7245953	Parker	Jul 2007	B1
7254429	Schurman et al.	Aug 2007	B2
7254431	Al-Ali et al.	Aug 2007	B2
7254433	Diab et al.	Aug 2007	B2
7254434	Schulz et al.	Aug 2007	B2
7272425	Al-Ali	Sep 2007	B2
7274955	Kiani et al.	Sep 2007	B2
D554263	Al-Ali et al.	Oct 2007	S
7280858	Al-Ali et al.	Oct 2007	B2
7289835	Mansfield et al.	Oct 2007	B2
7292883	De Felice et al.	Nov 2007	B2
7295866	Al-Ali	Nov 2007	B2
7311670	Just et al.	Dec 2007	B2
7328053	Diab et al.	Feb 2008	B1
7332784	Mills et al.	Feb 2008	B2
7340287	Mason et al.	Mar 2008	B2
7341559	Schulz et al.	Mar 2008	B2
7343186	Lamego et al.	Mar 2008	B2
D566282	Al-Ali et al.	Apr 2008	S
7355512	Al-Ali	Apr 2008	B1
7356365	Schurman et al.	Apr 2008	B2
7371981	Abdul-Hafiz	May 2008	B2
7373193	Al-Ali et al.	May 2008	B2
7373194	Weber et al.	May 2008	B2
7376453	Diab et al.	May 2008	B1
7377794	Al-Ali et al.	May 2008	B2
7377899	Weber et al.	May 2008	B2
7383070	Diab et al.	Jun 2008	B2
7395158	Monfre et al.	Jul 2008	B2
7415297	Al-Ali et al.	Aug 2008	B2
7428432	Ali et al.	Sep 2008	B2
7438683	Al-Ali et al.	Oct 2008	B2
7440787	Diab	Oct 2008	B2
7454240	Diab et al.	Nov 2008	B2
7467002	Weber et al.	Dec 2008	B2
7469157	Diab et al.	Dec 2008	B2
7471969	Diab et al.	Dec 2008	B2
7471971	Diab et al.	Dec 2008	B2
7483729	Al-Ali et al.	Jan 2009	B2
7483730	Diab et al.	Jan 2009	B2
7489958	Diab et al.	Feb 2009	B2
7496391	Diab et al.	Feb 2009	B2
7496393	Diab et al.	Feb 2009	B2
D587657	Al-Ali et al.	Mar 2009	S
7499741	Diab et al.	Mar 2009	B2
7499835	Weber et al.	Mar 2009	B2
7500950	Al-Ali et al.	Mar 2009	B2
7509154	Diab et al.	Mar 2009	B2
7509494	Al-Ali	Mar 2009	B2
7510849	Schurman et al.	Mar 2009	B2
7514725	Wojtczuk et al.	Apr 2009	B2
7519406	Blank et al.	Apr 2009	B2
7526328	Diab et al.	Apr 2009	B2
D592507	Wachman et al.	May 2009	S
7530942	Diab	May 2009	B1
7530949	Al Ali et al.	May 2009	B2
7530955	Diab et al.	May 2009	B2
7563110	Al-Ali et al.	Jul 2009	B2
7593230	Abul-Haj et al.	Sep 2009	B2
7596398	Al-Ali et al.	Sep 2009	B2
7606608	Blank et al.	Oct 2009	B2
7618375	Flaherty et al.	Nov 2009	B2
7620674	Ruchti et al.	Nov 2009	B2
D606659	Kiani et al.	Dec 2009	S
7629039	Eckerbom	Dec 2009	B2
7640140	Ruchti et al.	Dec 2009	B2
7647083	Al-Ali et al.	Jan 2010	B2
D609193	Al-Ali et al.	Feb 2010	S
7678057	Berkow et al.	Mar 2010	B2
D614305	Al-Ali et al.	Apr 2010	S
7697966	Monfre et al.	Apr 2010	B2
7698105	Ruchti et al.	Apr 2010	B2
RE41317	Parker	May 2010	E
RE41333	Blank et al.	May 2010	E
7729733	Al-Ali et al.	Jun 2010	B2
7734320	Al-Ali	Jun 2010	B2
7761127	Al-Ali et al.	Jul 2010	B2
7761128	Al-Ali et al.	Jul 2010	B2
7764982	Dalke et al.	Jul 2010	B2
D621516	Kiani et al.	Aug 2010	S
7791155	Diab	Sep 2010	B2
7801581	Diab	Sep 2010	B2
7822452	Schurman et al.	Oct 2010	B2
RE41912	Parker	Nov 2010	E
7844313	Kiani et al.	Nov 2010	B2
7844314	Al-Ali	Nov 2010	B2
7844315	Ai-Ali	Nov 2010	B2
7865222	Weber et al.	Jan 2011	B2
7873497	Weber et al.	Jan 2011	B2
7880606	Al-Ali	Feb 2011	B2
7880626	Al-Ali et al.	Feb 2011	B2
7891355	Al-Ali et al.	Feb 2011	B2
7894868	Al-Ali et al.	Feb 2011	B2
7899507	Al-Ali et al.	Mar 2011	B2
7899518	Trepagnier et al.	Mar 2011	B2
7904132	Weber et al.	Mar 2011	B2
7909772	Popov et al.	Mar 2011	B2
7910875	Al-Ali	Mar 2011	B2
7919713	Al-Ali et al.	Apr 2011	B2
7937128	Al-Ali	May 2011	B2
7937129	Mason et al.	May 2011	B2
7937130	Diab et al.	May 2011	B2
7941199	Kiani	May 2011	B2
7951086	Flaherty et al.	May 2011	B2
7957780	Lamego et al.	Jun 2011	B2
7962188	Kiani et al.	Jun 2011	B2
7962190	Diab et al.	Jun 2011	B1
7976472	Kiani	Jul 2011	B2
7988637	Diab	Aug 2011	B2
7990382	Kiani	Aug 2011	B2
7991446	Ali et al.	Aug 2011	B2
8000761	Al-Ali	Aug 2011	B2
8008088	Bellott et al.	Aug 2011	B2
RE42753	Kiani-Azarbayjany et al.	Sep 2011	E
8019400	Diab et al.	Sep 2011	B2
8028701	Al-Ali et al.	Oct 2011	B2
8029765	Bellott et al.	Oct 2011	B2
8036727	Schurman et al.	Oct 2011	B2
8036728	Diab et al.	Oct 2011	B2
8046040	Ali et al.	Oct 2011	B2
8046041	Diab et al.	Oct 2011	B2
8046042	Diab et al.	Oct 2011	B2
8048040	Kiani	Nov 2011	B2
8050728	Al-Ali et al.	Nov 2011	B2
RE43169	Parker	Feb 2012	E
8118620	Al-Ali et al.	Feb 2012	B2
8126528	Diab et al.	Feb 2012	B2
8128572	Diab et al.	Mar 2012	B2
8130105	Al-Ali et al.	Mar 2012	B2
8145287	Diab et al.	Mar 2012	B2
8150487	Diab et al.	Apr 2012	B2
8175672	Parker	May 2012	B2
8180420	Diab et al.	May 2012	B2
8182443	Kiani	May 2012	B1
8185180	Diab et al.	May 2012	B2
8190223	Al-Ali et al.	May 2012	B2
8190227	Diab et al.	May 2012	B2
8203438	Kiani et al.	Jun 2012	B2
8203704	Merritt et al.	Jun 2012	B2
8204566	Schurman et al.	Jun 2012	B2
8219172	Schurman et al.	Jul 2012	B2
8224411	Al-Ali et al.	Jul 2012	B2
8228181	Al-Ali	Jul 2012	B2
8229532	Davis	Jul 2012	B2
8229533	Diab et al.	Jul 2012	B2
8233955	Al-Ali et al.	Jul 2012	B2
8244325	Al-Ali et al.	Aug 2012	B2
8255026	Al-Ali	Aug 2012	B1
8255027	Al-Ali et al.	Aug 2012	B2
8255028	Al-Ali et al.	Aug 2012	B2
8260577	Weber et al.	Sep 2012	B2
8265723	McHale et al.	Sep 2012	B1
8274360	Sampath et al.	Sep 2012	B2
8280473	Al-Ali	Oct 2012	B2
8301217	Al-Ali et al.	Oct 2012	B2
8306596	Schurman et al.	Nov 2012	B2
8310336	Muhsin et al.	Nov 2012	B2
8315683	Al-Ali et al.	Nov 2012	B2
RE43860	Parker	Dec 2012	E
8337403	Al-Ali et al.	Dec 2012	B2
8346330	Lamego	Jan 2013	B2
8353842	Al-Ali et al.	Jan 2013	B2
8355766	MacNeish et al.	Jan 2013	B2
8359080	Diab et al.	Jan 2013	B2
8364223	Al-Ali et al.	Jan 2013	B2
8364226	Diab et al.	Jan 2013	B2
8374665	Lamego	Feb 2013	B2
8385995	Al-Ali et al.	Feb 2013	B2
8385996	Smith et al.	Feb 2013	B2
8388353	Kiani et al.	Mar 2013	B2
8399822	Al-Ali	Mar 2013	B2
8401602	Kiani	Mar 2013	B2
8405608	Al-Ali et al.	Mar 2013	B2
8414499	Al-Ali et al.	Apr 2013	B2
8418524	Al-Ali	Apr 2013	B2
8423106	Lamego et al.	Apr 2013	B2
8428967	Olsen et al.	Apr 2013	B2
8430817	Al-Ali et al.	Apr 2013	B1
8437825	Dalvi et al.	May 2013	B2
8455290	Siskavich	Jun 2013	B2
8457703	Al-Ali	Jun 2013	B2
8457707	Kiani	Jun 2013	B2
8463349	Diab et al.	Jun 2013	B2
8466286	Bellott et al.	Jun 2013	B2
8471713	Poeze et al.	Jun 2013	B2
8473020	Kiani et al.	Jun 2013	B2
8483787	Al-Ali et al.	Jul 2013	B2
8489364	Weber et al.	Jul 2013	B2
8498684	Weber et al.	Jul 2013	B2
8504128	Blank et al.	Aug 2013	B2
8509867	Workman et al.	Aug 2013	B2
8515509	Bruinsma et al.	Aug 2013	B2
8523781	Al-Ali	Sep 2013	B2
8529301	Al-Ali et al.	Sep 2013	B2
8532727	Ali et al.	Sep 2013	B2
8532728	Diab et al.	Sep 2013	B2
D692145	Al-Ali et al.	Oct 2013	S
8547209	Kiani et al.	Oct 2013	B2
8548548	Al-Ali	Oct 2013	B2
8548549	Schurman et al.	Oct 2013	B2
8548550	Al-Ali et al.	Oct 2013	B2
8560032	Al-Ali et al.	Oct 2013	B2
8560034	Diab et al.	Oct 2013	B1
8570167	Al-Ali	Oct 2013	B2
8570503	Vo et al.	Oct 2013	B2
8571617	Reichgott et al.	Oct 2013	B2
8571618	Lamego et al.	Oct 2013	B1
8571619	Al-Ali et al.	Oct 2013	B2
8577431	Lamego et al.	Nov 2013	B2
8581732	Al-Ali et al.	Nov 2013	B2
8584345	Al-Ali et al.	Nov 2013	B2
8588880	Abdul-Hafiz et al.	Nov 2013	B2
8600467	Al-Ali et al.	Dec 2013	B2
8606342	Diab	Dec 2013	B2
8626255	Al-Ali et al.	Jan 2014	B2
8630691	Lamego et al.	Jan 2014	B2
8634889	Al-Ali et al.	Jan 2014	B2
8641631	Sierra et al.	Feb 2014	B2
8652060	Al-Ali	Feb 2014	B2
8663107	Kiani	Mar 2014	B2
8666468	Al-Ali	Mar 2014	B1
8667967	Al-Ali et al.	Mar 2014	B2
8670811	O'Reilly	Mar 2014	B2
8670814	Diab et al.	Mar 2014	B2
8676286	Weber et al.	Mar 2014	B2
8682407	Al-Ali	Mar 2014	B2
RE44823	Parker	Apr 2014	E
RE44875	Kiani et al.	Apr 2014	E
8688183	Bruinsma et al.	Apr 2014	B2
8690799	Telfort et al.	Apr 2014	B2
8700112	Kiani	Apr 2014	B2
8702627	Telfort et al.	Apr 2014	B2
8706179	Parker	Apr 2014	B2
8712494	MacNeish, III et al.	Apr 2014	B1
8715206	Telfort et al.	May 2014	B2
8718735	Lamego et al.	May 2014	B2
8718737	Diab et al.	May 2014	B2
8718738	Blank et al.	May 2014	B2
8720249	Al-Ali	May 2014	B2
8721541	Al-Ali et al.	May 2014	B2
8721542	Al-Ali et al.	May 2014	B2
8723677	Kiani	May 2014	B1
8740792	Kiani et al.	Jun 2014	B1
8754776	Poeze et al.	Jun 2014	B2
8755535	Telfort et al.	Jun 2014	B2
8755856	Diab et al.	Jun 2014	B2
8755872	Marinow	Jun 2014	B1
8761850	Lamego	Jun 2014	B2
8764671	Kiani	Jul 2014	B2
8768423	Shakespeare et al.	Jul 2014	B2
8771204	Telfort et al.	Jul 2014	B2
8777634	Kiani et al.	Jul 2014	B2
8781543	Diab et al.	Jul 2014	B2
8781544	Al-Ali et al.	Jul 2014	B2
8781549	Al-Ali et al.	Jul 2014	B2
8788003	Schurman et al.	Jul 2014	B2
8790268	Al-Ali	Jul 2014	B2
8801613	Al-Ali et al.	Aug 2014	B2
8821397	Al-Ali et al.	Sep 2014	B2
8821415	Al-Ali et al.	Sep 2014	B2
8830449	Lamego et al.	Sep 2014	B1
8831700	Schurman et al.	Sep 2014	B2
8840549	Al-Ali et al.	Sep 2014	B2
8847740	Kiani et al.	Sep 2014	B2
8849365	Smith et al.	Sep 2014	B2
8852094	Al-Ali et al.	Oct 2014	B2
8852994	Wojtczuk et al.	Oct 2014	B2
8868147	Stippick et al.	Oct 2014	B2
8868150	Al-Ali et al.	Oct 2014	B2
8870792	Al-Ali et al.	Oct 2014	B2
8886271	Kiani et al.	Nov 2014	B2
8888539	Al-Ali et al.	Nov 2014	B2
8888708	Diab et al.	Nov 2014	B2
8892180	Weber et al.	Nov 2014	B2
8897847	Al-Ali	Nov 2014	B2
8909310	Lamego et al.	Dec 2014	B2
8911377	Al-Ali	Dec 2014	B2
8912909	Al-Ali et al.	Dec 2014	B2
8920317	Al-Ali et al.	Dec 2014	B2
8921699	Al-Ali et al.	Dec 2014	B2
8922382	Al-Ali et al.	Dec 2014	B2
8929964	Al-Ali et al.	Jan 2015	B2
8942777	Diab et al.	Jan 2015	B2
8948834	Diab et al.	Feb 2015	B2
8948835	Diab	Feb 2015	B2
8965471	Lamego	Feb 2015	B2
8983564	Al-Ali	Mar 2015	B2
8989831	Al-Ali et al.	Mar 2015	B2
8996085	Kiani et al.	Mar 2015	B2
8998809	Kiani	Apr 2015	B2
9028429	Telfort et al.	May 2015	B2
9037207	Al-Ali et al.	May 2015	B2
9060721	Reichgott et al.	Jun 2015	B2
9066666	Kiani	Jun 2015	B2
9066680	Al-Ali et al.	Jun 2015	B1
9072474	Al-Ali et al.	Jul 2015	B2
9078560	Schurman et al.	Jul 2015	B2
9084569	Weber et al.	Jul 2015	B2
9095316	Welch et al.	Aug 2015	B2
9106038	Telfort et al.	Aug 2015	B2
9107625	Telfort et al.	Aug 2015	B2
9107626	Al-Ali et al.	Aug 2015	B2
9113831	Al-Ali	Aug 2015	B2
9113832	Al-Ali	Aug 2015	B2
9119595	Lamego	Sep 2015	B2
9131881	Diab et al.	Sep 2015	B2
9131882	Al-Ali et al.	Sep 2015	B2
9131883	Al-Ali	Sep 2015	B2
9131917	Telfort et al.	Sep 2015	B2
9138180	Coverston et al.	Sep 2015	B1
9138182	Al-Ali et al.	Sep 2015	B2
9138192	Weber et al.	Sep 2015	B2
9142117	Muhsin et al.	Sep 2015	B2
9153112	Kiani et al.	Oct 2015	B1
9153121	Kiani et al.	Oct 2015	B2
9161696	Al-Ali et al.	Oct 2015	B2
9161713	Al-Ali et al.	Oct 2015	B2
9167995	Lamego et al.	Oct 2015	B2
9176141	Al-Ali et al.	Nov 2015	B2
9186102	Bruinsma et al.	Nov 2015	B2
9192312	Al-Ali	Nov 2015	B2
9192329	Al-Ali	Nov 2015	B2
9192351	Telfort et al.	Nov 2015	B1
9195385	Al-Ali et al.	Nov 2015	B2
9211072	Kiani	Dec 2015	B2
9211095	Al-Ali	Dec 2015	B1
9218454	Kiani et al.	Dec 2015	B2
9226696	Kiani	Jan 2016	B2
9241662	Al-Ali et al.	Jan 2016	B2
9245668	Vo et al.	Jan 2016	B1
9259185	Abdul-Hafiz et al.	Feb 2016	B2
9267572	Barker et al.	Feb 2016	B2
9277880	Poeze et al.	Mar 2016	B2
9289167	Diab et al.	Mar 2016	B2
9295421	Kiani et al.	Mar 2016	B2
9307928	Al-Ali et al.	Apr 2016	B1
9323894	Kiani	Apr 2016	B2
D755392	Hwang et al.	May 2016	S
9326712	Kiani	May 2016	B1
9333316	Kiani	May 2016	B2
9339220	Lamego et al.	May 2016	B2
9341565	Lamego et al.	May 2016	B2
9351673	Diab et al.	May 2016	B2
9351675	Al-Ali et al.	May 2016	B2
9364181	Kiani et al.	Jun 2016	B2
9368671	Wojtczuk et al.	Jun 2016	B2
9370325	Al-Ali et al.	Jun 2016	B2
9370326	McHale et al.	Jun 2016	B2
9370335	Al-Ali et al.	Jun 2016	B2
9375185	Ali et al.	Jun 2016	B2
9386953	Al-Ali	Jul 2016	B2
9386961	Al-Ali et al.	Jul 2016	B2
9392945	Al-Ali et al.	Jul 2016	B2
9397448	Al-Ali et al.	Jul 2016	B2
9408542	Kinast et al.	Aug 2016	B1
9436645	Al-Ali et al.	Sep 2016	B2
9445759	Lamego et al.	Sep 2016	B1
9466919	Kiani et al.	Oct 2016	B2
9474474	Lamego et al.	Oct 2016	B2
9480422	Al-Ali	Nov 2016	B2
9480435	Olsen	Nov 2016	B2
9492110	Al-Ali et al.	Nov 2016	B2
9510779	Poeze et al.	Dec 2016	B2
9517024	Kiani et al.	Dec 2016	B2
9532722	Lamego et al.	Jan 2017	B2
9538949	Al-Ali et al.	Jan 2017	B2
9538980	Telfort et al.	Jan 2017	B2
9549696	Lamego et al.	Jan 2017	B2
9554737	Schurman et al.	Jan 2017	B2
9560996	Kiani	Feb 2017	B2
9560998	Al-Ali et al.	Feb 2017	B2
9566019	Al-Ali et al.	Feb 2017	B2
9579039	Jansen et al.	Feb 2017	B2
9591975	Dalvi et al.	Mar 2017	B2
9622692	Lamego et al.	Apr 2017	B2
9622693	Diab	Apr 2017	B2
D788312	Al-Ali et al.	May 2017	S
9636055	Al Ali et al.	May 2017	B2
9636056	Al-Ali	May 2017	B2
9649054	Lamego et al.	May 2017	B2
9662052	Al-Ali et al.	May 2017	B2
9668679	Schurman et al.	Jun 2017	B2
9668680	Bruinsma et al.	Jun 2017	B2
9668703	Al-Ali	Jun 2017	B2
9675286	Diab	Jun 2017	B2
9687160	Kiani	Jun 2017	B2
9693719	Al-Ali et al.	Jul 2017	B2
9693737	Al-Ali	Jul 2017	B2
9697928	Al-Ali et al.	Jul 2017	B2
9717425	Kiani et al.	Aug 2017	B2
9717458	Lamego et al.	Aug 2017	B2
9724016	Al-Ali et al.	Aug 2017	B1
9724024	Al-Ali	Aug 2017	B2
9724025	Kiani et al.	Aug 2017	B1
9730640	Diab et al.	Aug 2017	B2
9743887	Al-Ali et al.	Aug 2017	B2
9749232	Sampath et al.	Aug 2017	B2
9750442	Olsen	Sep 2017	B2
9750443	Smith et al.	Sep 2017	B2
9750461	Telfort	Sep 2017	B1
9775545	Al-Ali et al.	Oct 2017	B2
9775546	Diab et al.	Oct 2017	B2
9775570	Al-Ali	Oct 2017	B2
9778079	Al-Ali et al.	Oct 2017	B1
9782077	Lamego et al.	Oct 2017	B2
9782110	Kiani	Oct 2017	B2
9787568	Lamego et al.	Oct 2017	B2
9788735	Al-Ali	Oct 2017	B2
9788768	Al-Ali et al.	Oct 2017	B2
9795300	Al-Ali	Oct 2017	B2
9795310	Al-Ali	Oct 2017	B2
9795358	Telfort et al.	Oct 2017	B2
9795739	Al-Ali et al.	Oct 2017	B2
9801556	Kiani	Oct 2017	B2
9801588	Weber et al.	Oct 2017	B2
9808188	Perea et al.	Nov 2017	B1
9814418	Weber et al.	Nov 2017	B2
9820691	Kiani	Nov 2017	B2
9833152	Kiani et al.	Dec 2017	B2
9833180	Shakespeare et al.	Dec 2017	B2
9839379	Al-Ali et al.	Dec 2017	B2
9839381	Weber et al.	Dec 2017	B1
9847002	Kiani et al.	Dec 2017	B2
9847749	Kiani et al.	Dec 2017	B2
9848800	Lee et al.	Dec 2017	B1
9848806	Al-Ali	Dec 2017	B2
9848807	Lamego	Dec 2017	B2
9861298	Eckerbom et al.	Jan 2018	B2
9861304	Al-Ali et al.	Jan 2018	B2
9861305	Weber et al.	Jan 2018	B1
9867578	Al-Ali et al.	Jan 2018	B2
9872623	Al-Ali	Jan 2018	B2
9876320	Coverston et al.	Jan 2018	B2
9877650	Muhsin et al.	Jan 2018	B2
9877686	Al-Ali et al.	Jan 2018	B2
9891079	Dalvi	Feb 2018	B2
9895107	Al-Ali et al.	Feb 2018	B2
9913617	Al-Ali et al.	Mar 2018	B2
9924893	Schurman et al.	Mar 2018	B2
9924897	Abdul-Hafiz	Mar 2018	B1
9936917	Poeze et al.	Apr 2018	B2
9943269	Muhsin et al.	Apr 2018	B2
9949676	Al-Ali et al.	Apr 2018	B2
9955937	Telfort	May 2018	B2
9965946	Al-Ali et al.	May 2018	B2
9980667	Kiani et al.	May 2018	B2
D820865	Muhsin et al.	Jun 2018	S
9986919	Lamego et al.	Jun 2018	B2
9986952	Dalvi et al.	Jun 2018	B2
9989560	Poeze et al.	Jun 2018	B2
9993207	Al-Ali et al.	Jun 2018	B2
10007758	Al-Ali et al.	Jun 2018	B2
D822215	Al-Ali et al.	Jul 2018	S
D822216	Barker et al.	Jul 2018	S
10010276	Al-Ali et al.	Jul 2018	B2
10032002	Kiani et al.	Jul 2018	B2
10039482	Al-Ali et al.	Aug 2018	B2
10052037	Kinast et al.	Aug 2018	B2
10058275	Al-Ali et al.	Aug 2018	B2
10064562	Al-Ali	Sep 2018	B2
10086138	Novak, Jr.	Oct 2018	B1
10092200	Al-Ali et al.	Oct 2018	B2
10092249	Kiani et al.	Oct 2018	B2
10098550	Al-Ali et al.	Oct 2018	B2
10098591	Al-Ali et al.	Oct 2018	B2
10098610	Al-Ali et al.	Oct 2018	B2
10111591	Dyell et al.	Oct 2018	B2
D833624	DeJong et al.	Nov 2018	S
10123726	Al-Ali et al.	Nov 2018	B2
10123729	Dyell et al.	Nov 2018	B2
10130289	Al-Ali et al.	Nov 2018	B2
10130291	Schurman et al.	Nov 2018	B2
D835282	Barker et al.	Dec 2018	S
D835283	Barker et al.	Dec 2018	S
D835284	Barker et al.	Dec 2018	S
D835285	Barker et al.	Dec 2018	S
10149616	Al-Ali et al.	Dec 2018	B2
10154815	Al-Ali et al.	Dec 2018	B2
10159412	Lamego et al.	Dec 2018	B2
10188296	Al-Ali et al.	Jan 2019	B2
10188331	Kiani et al.	Jan 2019	B1
10188348	Al-Ali et al.	Jan 2019	B2
RE47218	Al-Ali	Feb 2019	E
RE47244	Kiani et al.	Feb 2019	E
RE47249	Kiani et al.	Feb 2019	E
10194847	Al-Ali	Feb 2019	B2
10194848	Kiani et al.	Feb 2019	B1
10201298	Al-Ali et al.	Feb 2019	B2
10205272	Kiani et al.	Feb 2019	B2
10205291	Scruggs et al.	Feb 2019	B2
10213108	Al-Ali	Feb 2019	B2
10219706	Al-Ali	Mar 2019	B2
10219746	McHale et al.	Mar 2019	B2
10226187	Al-Ali et al.	Mar 2019	B2
10226576	Kiani	Mar 2019	B2
10231657	Al-Ali et al.	Mar 2019	B2
10231670	Blank et al.	Mar 2019	B2
10231676	Al-Ali et al.	Mar 2019	B2
RE47353	Kiani et al.	Apr 2019	E
10251585	Al-Ali et al.	Apr 2019	B2
10251586	Lamego	Apr 2019	B2
10255994	Sampath et al.	Apr 2019	B2
10258265	Poeze et al.	Apr 2019	B1
10258266	Poeze et al.	Apr 2019	B1
10271748	Al-Ali	Apr 2019	B2
10278626	Schurman et al.	May 2019	B2
10278648	Al-Ali et al.	May 2019	B2
10279247	Kiani	May 2019	B2
10292628	Poeze et al.	May 2019	B1
10292657	Abdul-Hafiz et al.	May 2019	B2
10292664	Al-Ali	May 2019	B2
10299708	Poeze et al.	May 2019	B1
10299709	Perea et al.	May 2019	B2
10299720	Brown et al.	May 2019	B2
10305775	Lamego et al.	May 2019	B2
10307111	Muhsin et al.	Jun 2019	B2
10325681	Sampath et al.	Jun 2019	B2
10327337	Schmidt et al.	Jun 2019	B2
10327713	Barker et al.	Jun 2019	B2
10332630	Al-Ali	Jun 2019	B2
10335033	Ai-Ai	Jul 2019	B2
10335068	Poeze et al.	Jul 2019	B2
10335072	Al-Ali et al.	Jul 2019	B2
10342470	Al-Ali et al.	Jul 2019	B2
10342487	Al-Ali et al.	Jul 2019	B2
10342497	Al-Ali et al.	Jul 2019	B2
10349895	Telfort et al.	Jul 2019	B2
10349898	Al-Ali et al.	Jul 2019	B2
10354504	Kiani et al.	Jul 2019	B2
10357206	Weber et al.	Jul 2019	B2
10357209	Al-Ali	Jul 2019	B2
10366787	Sampath et al.	Jul 2019	B2
10368787	Reichgott et al.	Aug 2019	B2
10376190	Poeze et al.	Aug 2019	B1
10376191	Poeze et al.	Aug 2019	B1
10383520	Wojtczuk et al.	Aug 2019	B2
10383527	Al-Ali	Aug 2019	B2
10388120	Muhsin et al.	Aug 2019	B2
10398320	Kiani et al.	Sep 2019	B2
10405804	Al-Ali	Sep 2019	B2
10413666	Al-Ali et al.	Sep 2019	B2
10420493	Al-Ali et al.	Sep 2019	B2
D864120	Forrest et al.	Oct 2019	S
10433776	Al-Ali	Oct 2019	B2
10441181	Telfort et al.	Oct 2019	B1
10441196	Eckerbom et al.	Oct 2019	B2
10448844	Al-Ali et al.	Oct 2019	B2
10448871	Al-Ali et al.	Oct 2019	B2
10456038	Lamego et al.	Oct 2019	B2
10463284	Al-Ali et al.	Nov 2019	B2
10463340	Telfort et al.	Nov 2019	B2
10470695	Al-Ali et al.	Nov 2019	B2
10471159	Lapotko et al.	Nov 2019	B1
10478107	Kiani et al.	Nov 2019	B2
10503379	Al-Ali et al.	Dec 2019	B2
10505311	Al-Ali et al.	Dec 2019	B2
10512436	Muhsin et al.	Dec 2019	B2
10524706	Telfort et al.	Jan 2020	B2
10524738	Olsen	Jan 2020	B2
10531811	Al-Ali et al.	Jan 2020	B2
10531819	Diab et al.	Jan 2020	B2
10531835	Al-Ali et al.	Jan 2020	B2
10532174	Al-Ali	Jan 2020	B2
10537285	Shreim et al.	Jan 2020	B2
10542903	Al-Ali et al.	Jan 2020	B2
10548561	Telfort et al.	Feb 2020	B2
10555678	Dalvi et al.	Feb 2020	B2
10568514	Wojtczuk et al.	Feb 2020	B2
10568553	O'Neil et al.	Feb 2020	B2
RE47882	Al-Ali	Mar 2020	E
10575779	Poeze et al.	Mar 2020	B2
10582886	Poeze et al.	Mar 2020	B2
10588518	Kiani	Mar 2020	B2
10588553	Poeze et al.	Mar 2020	B2
10588556	Kiani et al.	Mar 2020	B2
10608817	Haider et al.	Mar 2020	B2
D880477	Forrest et al.	Apr 2020	S
10617302	Al-Ali et al.	Apr 2020	B2
10617335	Al-Ali et al.	Apr 2020	B2
10637181	Al-Ali et al.	Apr 2020	B2
D886849	Muhsin et al.	Jun 2020	S
D887548	Abdul-Hafiz et al.	Jun 2020	S
D887549	Abdul-Hafiz et al.	Jun 2020	S
10667764	Ahmed et al.	Jun 2020	B2
D890708	Forrest et al.	Jul 2020	S
10721785	Al-Ali	Jul 2020	B2
10736518	Al-Ali et al.	Aug 2020	B2
10750984	Pauley et al.	Aug 2020	B2
D897098	Al-Ali	Sep 2020	S
10779098	Iswanto et al.	Sep 2020	B2
10827961	Iyengar et al.	Nov 2020	B1
10828007	Telfort et al.	Nov 2020	B1
10832818	Muhsin et al.	Nov 2020	B2
10849554	Shreim et al.	Dec 2020	B2
10856750	Indorf	Dec 2020	B2
D906970	Forrest et al.	Jan 2021	S
D908213	Abdul-Hafiz et al.	Jan 2021	S
10918281	Al-Ali et al.	Feb 2021	B2
10932705	Muhsin et al.	Mar 2021	B2
10932729	Kiani et al.	Mar 2021	B2
10939878	Kiani et al.	Mar 2021	B2
10956950	Al-Ali et al.	Mar 2021	B2
D916135	Indorf et al.	Apr 2021	S
D917046	Abdul-Hafiz et al.	Apr 2021	S
D917550	Indorf et al.	Apr 2021	S
D917564	Indorf et al.	Apr 2021	S
D917704	Al-Ali et al.	Apr 2021	S
10987066	Chandran et al.	Apr 2021	B2
10991135	Al-Ali et al.	Apr 2021	B2
D919094	Al-Ali et al.	May 2021	S
D919100	Al-Ali et al.	May 2021	S
11006867	Ai-Ali	May 2021	B2
D921202	Al-Ali et al.	Jun 2021	S
11024064	Muhsin et al.	Jun 2021	B2
11026604	Chen et al.	Jun 2021	B2
D925597	Chandran et al.	Jul 2021	S
D927699	Al-Ali et al.	Aug 2021	S
11076777	Lee et al.	Aug 2021	B2
11114188	Poeze et al.	Sep 2021	B2
D933232	Al-Ali et al.	Oct 2021	S
D933233	Al-Ali et al.	Oct 2021	S
D933234	Al-Ali et al.	Oct 2021	S
11145408	Sampath et al.	Oct 2021	B2
11147518	Al-Ali et al.	Oct 2021	B1
11185262	Al-Ali et al.	Nov 2021	B2
11191484	Kiani et al.	Dec 2021	B2
D946596	Ahmed	Mar 2022	S
D946597	Ahmed	Mar 2022	S
D946598	Ahmed	Mar 2022	S
D946617	Ahmed	Mar 2022	S
11272839	Al-Ali et al.	Mar 2022	B2
11272852	Lamego	Mar 2022	B2
11289199	Al-Ali	Mar 2022	B2
RE49034	Al-Ali	Apr 2022	E
11298021	Muhsin et al.	Apr 2022	B2
D950580	Ahmed	May 2022	S
D950599	Ahmed	May 2022	S
D950738	Al-Ali et al.	May 2022	S
D957648	Al-Ali	Jul 2022	S
11382567	O'Brien et al.	Jul 2022	B2
11389093	Triman et al.	Jul 2022	B2
11406286	Al-Ali et al.	Aug 2022	B2
11417426	Muhsin et al.	Aug 2022	B2
11439329	Lamego	Sep 2022	B2
11445948	Scruggs et al.	Sep 2022	B2
D965789	Al-Ali et al.	Oct 2022	S
D967433	Al-Ali et al.	Oct 2022	S
11464410	Muhsin	Oct 2022	B2
11504058	Sharma et al.	Nov 2022	B1
11504066	Dalvi et al.	Nov 2022	B1
D971933	Ahmed	Dec 2022	S
D973072	Ahmed	Dec 2022	S
D973685	Ahmed	Dec 2022	S
D973686	Ahmed	Dec 2022	S
D974193	Forrest et al.	Jan 2023	S
D979516	Al-Ali et al.	Feb 2023	S
D980091	Forrest et al.	Mar 2023	S
11596363	Lamego	Mar 2023	B2
11627919	Kiani et al.	Apr 2023	B2
11637437	Al-Ali et al.	Apr 2023	B2
D985498	Al-Ali et al.	May 2023	S
11653862	Dalvi et al.	May 2023	B2
D989112	Muhsin et al.	Jun 2023	S
11678829	Al-Ali et al.	Jun 2023	B2
11692934	Normand et al.	Jul 2023	B2
20010034477	Mansfield et al.	Oct 2001	A1
20010039483	Brand et al.	Nov 2001	A1
20020010401	Bushmakin et al.	Jan 2002	A1
20020058864	Mansfield et al.	May 2002	A1
20020133080	Apruzzese et al.	Sep 2002	A1
20030013975	Kiani	Jan 2003	A1
20030018243	Gerhardt et al.	Jan 2003	A1
20030125609	Becker	Jul 2003	A1
20030144582	Cohen et al.	Jul 2003	A1
20030156288	Barnum et al.	Aug 2003	A1
20030205578	Newport	Nov 2003	A1
20030212312	Coffin, IV et al.	Nov 2003	A1
20040106163	Workman, Jr. et al.	Jun 2004	A1
20050055276	Kiani et al.	Mar 2005	A1
20050056747	Belcourt et al.	Mar 2005	A1
20050234317	Kiani	Oct 2005	A1
20050288571	Perkins et al.	Dec 2005	A1
20050288597	Kishimoto et al.	Dec 2005	A1
20060073719	Kiani	Apr 2006	A1
20060161054	Reuss et al.	Jul 2006	A1
20060189871	Al-Ali et al.	Aug 2006	A1
20060211923	Al-Ali et al.	Sep 2006	A1
20070073116	Kiani et al.	Mar 2007	A1
20070073173	Lam et al.	Mar 2007	A1
20070180140	Welch et al.	Aug 2007	A1
20070221056	Kutella	Sep 2007	A1
20070244363	Sano	Oct 2007	A1
20070244377	Cozad et al.	Oct 2007	A1
20070276263	Eide	Nov 2007	A1
20070282478	Al-Ali et al.	Dec 2007	A1
20070287923	Adkins et al.	Dec 2007	A1
20080001735	Tran	Jan 2008	A1
20080045846	Friedman et al.	Feb 2008	A1
20080064965	Jay et al.	Mar 2008	A1
20080094228	Welch et al.	Apr 2008	A1
20080221418	Al-Ali et al.	Sep 2008	A1
20080236586	McDonald et al.	Oct 2008	A1
20080287814	Muehsteff	Nov 2008	A1
20080294455	Bharara	Nov 2008	A1
20090036759	Ault et al.	Feb 2009	A1
20090093687	Telfort et al.	Apr 2009	A1
20090095926	MacNeish, III	Apr 2009	A1
20090126482	Fundak	May 2009	A1
20090194718	Kulesha	Aug 2009	A1
20090234381	Karo	Sep 2009	A1
20090247984	Lamego et al.	Oct 2009	A1
20090275813	Davis	Nov 2009	A1
20090275844	Al-Ali	Nov 2009	A1
20100004518	Vo et al.	Jan 2010	A1
20100030040	Poeze et al.	Feb 2010	A1
20100099964	O'Reilly et al.	Apr 2010	A1
20100211096	McEwen et al.	Aug 2010	A1
20100234698	Manstrom et al.	Sep 2010	A1
20100234718	Sampath et al.	Sep 2010	A1
20100270257	Wachman et al.	Oct 2010	A1
20110009757	Sano et al.	Jan 2011	A1
20110028806	Merritt et al.	Feb 2011	A1
20110028809	Goodman	Feb 2011	A1
20110040197	Welch et al.	Feb 2011	A1
20110066009	Moon	Mar 2011	A1
20110082711	Poeze et al.	Apr 2011	A1
20110087081	Kiani et al.	Apr 2011	A1
20110092827	Hu et al.	Apr 2011	A1
20110105854	Kiani et al.	May 2011	A1
20110112412	Sano et al.	May 2011	A1
20110118561	Tari et al.	May 2011	A1
20110125060	Telfort et al.	May 2011	A1
20110137297	Kiani et al.	Jun 2011	A1
20110152785	Chattaraj et al.	Jun 2011	A1
20110166459	Kopetsch et al.	Jul 2011	A1
20110172498	Olsen et al.	Jul 2011	A1
20110196211	Al-Ali	Aug 2011	A1
20110208015	Welch et al.	Aug 2011	A1
20110230733	Al-Ali	Sep 2011	A1
20120041276	Doreus et al.	Feb 2012	A1
20120059267	Lamego	Mar 2012	A1
20120123231	O'Reilly	May 2012	A1
20120157791	Hersh	Jun 2012	A1
20120165629	Merritt et al.	Jun 2012	A1
20120209082	Al-Ali	Aug 2012	A1
20120209084	Olsen et al.	Aug 2012	A1
20120226117	Lamego et al.	Sep 2012	A1
20120232416	Gilham	Sep 2012	A1
20120240377	Ashida	Sep 2012	A1
20120283524	Kiani et al.	Nov 2012	A1
20120316449	Uesaka et al.	Dec 2012	A1
20120319816	Al-Ali	Dec 2012	A1
20120330169	Sano et al.	Dec 2012	A1
20130023775	Lamego et al.	Jan 2013	A1
20130041591	Lamego	Feb 2013	A1
20130060147	Welch et al.	Mar 2013	A1
20130060153	Kobayashi et al.	Mar 2013	A1
20130096405	Garfio	Apr 2013	A1
20130096936	Sampath et al.	Apr 2013	A1
20130138000	Kinoshita et al.	May 2013	A1
20130243021	Siskavich	Sep 2013	A1
20130253334	Al-Ali et al.	Sep 2013	A1
20130296672	O'Neil et al.	Nov 2013	A1
20130296713	Al-Ali et al.	Nov 2013	A1
20130324808	Al-Ali et al.	Dec 2013	A1
20130331660	Al-Ali et al.	Dec 2013	A1
20130345921	Al-Ali et al.	Dec 2013	A1
20140012100	Al-Ali et al.	Jan 2014	A1
20140051953	Lamego et al.	Feb 2014	A1
20140081175	Telfort	Mar 2014	A1
20140120564	Workman et al.	May 2014	A1
20140121482	Merritt et al.	May 2014	A1
20140127137	Bellott et al.	May 2014	A1
20140135588	Al-Ali et al.	May 2014	A1
20140163344	Al-Ali	Jun 2014	A1
20140166076	Kiani et al.	Jun 2014	A1
20140171763	Diab	Jun 2014	A1
20140180038	Kiani	Jun 2014	A1
20140180154	Sierra et al.	Jun 2014	A1
20140180160	Brown et al.	Jun 2014	A1
20140187973	Brown et al.	Jul 2014	A1
20140213864	Abdul-Hafiz et al.	Jul 2014	A1
20140266790	Al-Ali et al.	Sep 2014	A1
20140275808	Poeze et al.	Sep 2014	A1
20140275835	Lamego et al.	Sep 2014	A1
20140275871	Lamego et al.	Sep 2014	A1
20140275872	Merritt et al.	Sep 2014	A1
20140276115	Dalvi et al.	Sep 2014	A1
20140288400	Diab et al.	Sep 2014	A1
20140316217	Purdon et al.	Oct 2014	A1
20140316218	Purdon et al.	Oct 2014	A1
20140316228	Blank et al.	Oct 2014	A1
20140323825	Al-Ali et al.	Oct 2014	A1
20140323897	Brown et al.	Oct 2014	A1
20140323898	Purdon et al.	Oct 2014	A1
20140330092	Al-Ali et al.	Nov 2014	A1
20140330098	Merritt et al.	Nov 2014	A1
20140357966	Al-Ali et al.	Dec 2014	A1
20150005600	Blank et al.	Jan 2015	A1
20150011907	Purdon et al.	Jan 2015	A1
20150012231	Poeze et al.	Jan 2015	A1
20150032029	Al-Ali et al.	Jan 2015	A1
20150038859	Dalvi et al.	Feb 2015	A1
20150073241	Lamego	Mar 2015	A1
20150080754	Purdon et al.	Mar 2015	A1
20150087936	Al-Ali et al.	Mar 2015	A1
20150094546	Al-Ali	Apr 2015	A1
20150097701	Al-Ali et al.	Apr 2015	A1
20150099950	Al-Ali et al.	Apr 2015	A1
20150099955	Al-Ali et al.	Apr 2015	A1
20150101844	Al-Ali et al.	Apr 2015	A1
20150106121	Muhsin et al.	Apr 2015	A1
20150112151	Muhsin et al.	Apr 2015	A1
20150116076	Al-Ali et al.	Apr 2015	A1
20150165312	Kiani	Jun 2015	A1
20150196249	Brown et al.	Jul 2015	A1
20150216459	Al-Ali et al.	Aug 2015	A1
20150238722	Al-Ali	Aug 2015	A1
20150245773	Lamego et al.	Sep 2015	A1
20150245794	Al-Ali	Sep 2015	A1
20150257689	Al-Ali et al.	Sep 2015	A1
20150272514	Kiani et al.	Oct 2015	A1
20150351697	Weber et al.	Dec 2015	A1
20150359429	Al-Ali et al.	Dec 2015	A1
20150366507	Blank	Dec 2015	A1
20160029932	Al-Ali	Feb 2016	A1
20160058347	Reichgott et al.	Mar 2016	A1
20160066824	Al-Ali et al.	Mar 2016	A1
20160081552	Wojtczuk et al.	Mar 2016	A1
20160095543	Telfort et al.	Apr 2016	A1
20160095548	Al-Ali et al.	Apr 2016	A1
20160103598	Al-Ali et al.	Apr 2016	A1
20160143548	Al-Ali	May 2016	A1
20160166182	Al-Ali et al.	Jun 2016	A1
20160166183	Poeze et al.	Jun 2016	A1
20160192869	Kiani et al.	Jul 2016	A1
20160196388	Lamego	Jul 2016	A1
20160197436	Barker et al.	Jul 2016	A1
20160213281	Eckerbom et al.	Jul 2016	A1
20160228043	O'Neil et al.	Aug 2016	A1
20160233632	Scruggs et al.	Aug 2016	A1
20160234944	Schmidt et al.	Aug 2016	A1
20160270735	Diab et al.	Sep 2016	A1
20160283665	Sampath et al.	Sep 2016	A1
20160287090	Al-Ali et al.	Oct 2016	A1
20160287786	Kiani	Oct 2016	A1
20160296169	McHale et al.	Oct 2016	A1
20160310052	Al-Ali et al.	Oct 2016	A1
20160314260	Kiani	Oct 2016	A1
20160324486	Al-Ali et al.	Nov 2016	A1
20160324488	Olsen	Nov 2016	A1
20160327984	Al-Ali et al.	Nov 2016	A1
20160328528	Al-Ali et al.	Nov 2016	A1
20160331332	Al-Ali	Nov 2016	A1
20160367173	Dalvi et al.	Dec 2016	A1
20170000394	Al-Ali et al.	Jan 2017	A1
20170007134	Al-Ali et al.	Jan 2017	A1
20170007198	Al-Ali et al.	Jan 2017	A1
20170014083	Diab et al.	Jan 2017	A1
20170014084	Al-Ali et al.	Jan 2017	A1
20170024748	Haider	Jan 2017	A1
20170027456	Kinast et al.	Feb 2017	A1
20170042488	Muhsin	Feb 2017	A1
20170055851	Al-Ali	Mar 2017	A1
20170055882	Al-Ali et al.	Mar 2017	A1
20170055887	Al-Ali	Mar 2017	A1
20170055896	Al-Ali	Mar 2017	A1
20170079594	Telfort et al.	Mar 2017	A1
20170086723	Al-Ali et al.	Mar 2017	A1
20170143281	Olsen	May 2017	A1
20170147774	Kiani	May 2017	A1
20170156620	Al-Ali et al.	Jun 2017	A1
20170173632	Al-Ali	Jun 2017	A1
20170187146	Kiani et al.	Jun 2017	A1
20170188919	Al-Ali et al.	Jul 2017	A1
20170196464	Jansen et al.	Jul 2017	A1
20170202490	Al-Ali et al.	Jul 2017	A1
20170224262	Al-Ali	Aug 2017	A1
20170228516	Sampath et al.	Aug 2017	A1
20170245790	Al-Ali et al.	Aug 2017	A1
20170251974	Shreim et al.	Sep 2017	A1
20170251975	Shreim et al.	Sep 2017	A1
20170258403	Abdul-Hafiz et al.	Sep 2017	A1
20170311891	Kiani et al.	Nov 2017	A1
20170325728	Al-Ali et al.	Nov 2017	A1
20170332976	Al-Ali et al.	Nov 2017	A1
20170340293	Al-Ali et al.	Nov 2017	A1
20170360310	Kiani	Dec 2017	A1
20170367632	Al-Ali et al.	Dec 2017	A1
20180008146	Al-Ali et al.	Jan 2018	A1
20180013562	Haider et al.	Jan 2018	A1
20180014752	Al-Ali et al.	Jan 2018	A1
20180028124	Al-Ali et al.	Feb 2018	A1
20180055385	Al-Ali	Mar 2018	A1
20180055390	Kiani et al.	Mar 2018	A1
20180055430	Diab et al.	Mar 2018	A1
20180064381	Shakespeare et al.	Mar 2018	A1
20180069776	Lamego et al.	Mar 2018	A1
20180103874	Lee et al.	Apr 2018	A1
20180192924	Al-Ali	Jul 2018	A1
20180192953	Shreim et al.	Jul 2018	A1
20180199871	Pauley et al.	Jul 2018	A1
20180213583	Al-Ali	Jul 2018	A1
20180218792	Al-Ali	Aug 2018	A1
20180242923	Al-Ali et al.	Aug 2018	A1
20180242924	Barker et al.	Aug 2018	A1
20180242926	Muhsin et al.	Aug 2018	A1
20180247353	Al-Ali et al.	Aug 2018	A1
20180247712	Muhsin et al.	Aug 2018	A1
20180249933	Schurman et al.	Sep 2018	A1
20180253947	Muhsin et al.	Sep 2018	A1
20180256087	Al-Ali et al.	Sep 2018	A1
20180256113	Weber et al.	Sep 2018	A1
20180285094	Housel et al.	Oct 2018	A1
20180289337	Al-Ali et al.	Oct 2018	A1
20180296161	Shreim et al.	Oct 2018	A1
20180300919	Muhshin et al.	Oct 2018	A1
20180310822	Indorf et al.	Nov 2018	A1
20180310823	Al-Ali et al.	Nov 2018	A1
20180317826	Muhsin et al.	Nov 2018	A1
20180317841	Novak, Jr.	Nov 2018	A1
20180333055	Lamego et al.	Nov 2018	A1
20180333087	Al-Ali	Nov 2018	A1
20190000317	Muhsin et al.	Jan 2019	A1
20190015023	Monfre	Jan 2019	A1
20190058280	Al-Ali et al.	Feb 2019	A1
20190117070	Muhsin et al.	Apr 2019	A1
20190200941	Chandran et al.	Jul 2019	A1
20190201623	Kiani	Jul 2019	A1
20190209025	Al-Ali	Jul 2019	A1
20190221966	Kiani et al.	Jul 2019	A1
20190239787	Pauley et al.	Aug 2019	A1
20190290136	Dalvi et al.	Sep 2019	A1
20190298270	Al-Ali et al.	Oct 2019	A1
20190320906	Olsen	Oct 2019	A1
20190320988	Ahmed et al.	Oct 2019	A1
20190374139	Kiani et al.	Dec 2019	A1
20190374173	Kiani et al.	Dec 2019	A1
20190374713	Kiani et al.	Dec 2019	A1
20200021930	Iswanto et al.	Jan 2020	A1
20200046257	Eckerbom et al.	Feb 2020	A1
20200060869	Telfort et al.	Feb 2020	A1
20200111552	Ahmed	Apr 2020	A1
20200113435	Muhsin	Apr 2020	A1
20200113488	Al-Ali et al.	Apr 2020	A1
20200113496	Scruggs et al.	Apr 2020	A1
20200113497	Triman et al.	Apr 2020	A1
20200113520	Abdul-Hafiz et al.	Apr 2020	A1
20200138288	Al-Ali et al.	May 2020	A1
20200138368	Kiani et al.	May 2020	A1
20200163597	Dalvi et al.	May 2020	A1
20200196877	Vo et al.	Jun 2020	A1
20200253474	Muhsin et al.	Aug 2020	A1
20200253544	Belur Nagaraj et al.	Aug 2020	A1
20200275841	Telfort et al.	Sep 2020	A1
20200288983	Telfort et al.	Sep 2020	A1
20200321793	Al-Ali et al.	Oct 2020	A1
20200329983	Al-Ali et al.	Oct 2020	A1
20200329984	Al-Ali et al.	Oct 2020	A1
20200329993	Al-Ali et al.	Oct 2020	A1
20200330037	Al-Ali et al.	Oct 2020	A1
20210022628	Telfort et al.	Jan 2021	A1
20210104173	Pauley et al.	Apr 2021	A1
20210113121	Diab et al.	Apr 2021	A1
20210117525	Kiani et al.	Apr 2021	A1
20210118581	Kiani et al.	Apr 2021	A1
20210121582	Krishnamani et al.	Apr 2021	A1
20210161465	Barker et al.	Jun 2021	A1
20210236729	Kiani et al.	Aug 2021	A1
20210256267	Ranasinghe et al.	Aug 2021	A1
20210256835	Ranasinghe et al.	Aug 2021	A1
20210275101	Vo et al.	Sep 2021	A1
20210290060	Ahmed	Sep 2021	A1
20210290072	Forrest	Sep 2021	A1
20210290080	Ahmed	Sep 2021	A1
20210290120	Al-Ali	Sep 2021	A1
20210290177	Novak, Jr.	Sep 2021	A1
20210290184	Ahmed	Sep 2021	A1
20210296008	Novak, Jr.	Sep 2021	A1
20210330228	Olsen et al.	Oct 2021	A1
20210386382	Olsen et al.	Dec 2021	A1
20210402110	Pauley et al.	Dec 2021	A1
20220026355	Normand et al.	Jan 2022	A1
20220039707	Sharma et al.	Feb 2022	A1
20220053892	Al-Ali et al.	Feb 2022	A1
20220071562	Kiani	Mar 2022	A1
20220096603	Kiani et al.	Mar 2022	A1
20220151521	Krishnamani et al.	May 2022	A1
20220218244	Kiani et al.	Jul 2022	A1
20220287574	Telfort et al.	Sep 2022	A1
20220296161	Al-Ali et al.	Sep 2022	A1
20220361819	Al-Ali et al.	Nov 2022	A1
20220379059	Yu et al.	Dec 2022	A1
20220392610	Kiani et al.	Dec 2022	A1
20230028745	Al-Ali	Jan 2023	A1
20230038389	Vo	Feb 2023	A1
20230045647	Vo	Feb 2023	A1
20230058052	Al-Ali	Feb 2023	A1
20230058342	Kiani	Feb 2023	A1
20230069789	Koo et al.	Mar 2023	A1
20230087671	Telfort et al.	Mar 2023	A1
20230110152	Forrest et al.	Apr 2023	A1
20230111198	Yu et al.	Apr 2023	A1
20230115397	Vo et al.	Apr 2023	A1
20230116371	Mills et al.	Apr 2023	A1
20230135297	Kiani et al.	May 2023	A1
20230138098	Telfort et al.	May 2023	A1
20230145155	Krishnamani et al.	May 2023	A1
20230147750	Barker et al.	May 2023	A1
20230210417	Al-Ali et al.	Jul 2023	A1
20230222805	Muhsin et al.	Jul 2023	A1
20230222887	Muhsin et al.	Jul 2023	A1

Foreign Referenced Citations (5)

Number	Date	Country
948 351	Jan 1964	GB
WO 2007137347	Dec 2007	WO
WO 2009153710	Dec 2009	WO
WO 2013170095	Nov 2013	WO
WO 2015020911	Feb 2015	WO

Non-Patent Literature Citations (13)

Entry
US 2022/0192529 A1, 06/2022, Al-Ali et al. (withdrawn)
Advanced/Deluxe One Step Auto-Inflation Blood Pressure Monitor Model UA-767 Plus. User guide[online]. Life Source, 2009 [retrieved on Apr. 28, 2016]. Retrieved from internet https://www.andonline.com/uploads/documents/I-MAN-UA-767PV_0409.pdf.
Bureau of Indian Standards: “Fire Extinguisher, Carbon Dioxide Type (Portable and Trolley Mounted)—Specification.” Aug. 1, 2004, retrieved from the internet: https://law.resource.org/pub/in/bis/S03/is.2878.2004.html.
Innovations Ultraflate Plus: https://www.youtube.com/watch?v=nUcx-e91zz0 (1 page).
Innovations Ultraflate Plus CO2 Amazon customer review, Mar. 2008: http://www.amazon.com/Genuine-Innovations-2425-Ultraflate-Plus/product-reviews/800278X00Q (4 pages).
International Search Report and Written Opinion received in PCT Application No. PCT/US2013/040438, dated Jul. 26, 2013.
International Search Report and Written Opinion received in PCT Application No. PCT/US2014/049490, dated Mar. 31, 2015.
International Preliminary Report on Patentability and Written Opinion received in PCT Application No. PCT/US2013/040438, dated Nov. 20, 2014.
International Preliminary Report on Patentability and Written Opinion received in PCT Application No. PCT/US2014/049490, dated Feb. 18, 2016.
Invitation to Pay Fees received in PCT Application No. PCT/US2014/049490, dated Nov. 26, 2014.
Jun Onoderan, Validation of Infationary non-invasive blood pressure monitoring in adult surgical patients, Journal of Anesthesiology, 2011, vol. 25, pp. 127-130.
Osamu Tochikubo, A New Portable Device for Recording 24-h Indirect Blood Pressure in Hypertensive Outpatients, Journal of Hypertension, 1985, vol. 3, pp. 335-357.
Ultraflate: http://www.genuineinnovations.com/us/products/inflators/ultraflate.php (2 pages).

Related Publications (1)

	Number	Date	Country
	20230019452 A1	Jan 2023	US

Provisional Applications (2)

	Number	Date	Country
	61499515	Jun 2011	US
	61645570	May 2012	US

Continuations (2)

	Number	Date	Country
Parent	15388605	Dec 2016	US
Child	17653377		US
Parent	13527370	Jun 2012	US
Child	15388605		US

Patient monitoring system

Information

Patent Number

Date Filed

Date Issued

Inventors

Original Assignees

Examiners

Agents

CPC

Field of Search

CPC

International Classifications

Abstract